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INTRODUCTION 
Sulfhydryl groups of enzymes and membrane proteins are 
involved in essential metabolic and biosynthetic processes 
and also are important in retaining integrity of 
macromolecules (1-4). Small sulfhydryl-containing 
molecules are known to play an important part as protective 
and repair agents (5) and may have a regulatory function 
(6). Glutathione (GSH: a tripeptide 
7-glutamylcysteinylglycine), is a well studied and the most 
abundant nonprotein thiol in living systems. It is found 
in the intracellular milieu of animals, plants, and 
microorganisms (7), i.e., in cytoplasm, nucleus, and 
mitochondria (8,9). Glutathione plays an important role in 
detoxification of variety of exogenous compounds (10,11). 
GSH can act either as a nucleophile forming conjugates with 
electrophilic drugs and carcinogenic metabolites, or as a 
reductant in the metabolism of hydroperoxides and free 
radicals (12,13). During oxidative stress, either by 
generation of oxygen free radicals or by treatment with 
oxidants disturbing prooxidant-antioxidant balance in favor 
of former, the intracellular glutathione pool is oxidized 
and the S-thiolation of proteins (formation of protein 
mixed-disulfides) is increased. Our laboratory has studied 
the role of protein S-thiolation and dethiolation 
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(reduction of S-thiolated proteins) during oxidative 
stress. To understand the importance of protein 
S-thiolation, we studied the possible mechanisms of protein 
S-thiolation and dethiolation. 
S-Thiolation 
Protein S-thiolation is the formation of protein 
mixed-disulfides between reactive sulfhydryls on proteins 
and low molecular weight thiols. It has been reported to 
occur during oxidative stress either by free radical-
induced oxidative stress (14-17) or by non-radical type of 
oxidative stress such as treatment with oxidant diamide 
(18-20). Various low molecular weight thiols have been 
Oxidative Stress 
Protein-SH Protein-S-SR 
RSH 
RSH: a low molecular weight thiol 
investigated as participants in S-thiolation (21-23). The 
nature of the low molecular weight thiols in in vivo S-
thiolation studies was identified in only few cases. 
Furthermore, thiols released from S-thiolated proteins by 
chemical reduction were measured with a nonspecific thiol 
reagent in those experiments (15,16,24). The studies 
presented in this dissertation focused on protein S-
thiolation with glutathione since glutathione is the most 
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abundant low molecular weight thiol. 
Under physiological conditions, the redox state of 
cellular proteins and low molecular weight thiols is 
reduced, therefore, the cellular content of S-thiolated 
proteins is undetectably low (20,25). However, under 
oxidative stress, disulfides are increased with concomitant 
decrease in reduced thiols and protein S-thiolation is 
increased. Under normal conditions, the cellular 
glutathione pool is in the reduced state (the ratio of 
GSH/GSSG is approximately 200) (19,20,26). When cells are 
treated with an oxidative stress agent, glutathione is 
oxidized to glutathione disulfide (GSSG) either by 
glutathione peroxidase (27-29) or by nonenzymatic reaction 
with oxyradicals (30-32). The GSSG formed is subsequently 
reduced by glutathione reductase at the expense of NADPH 
(28). However, when the rate of GSSG formation exceeds 
that of its reduction, or when NADPH becomes rate-limiting 
for glutathione reductase, intracellular accumulation of 
GSSG occurs. Under these conditions, an efflux of GSSG 
follows its intracellular accumulation as an attempt to 
keep the glutathione pool reduced. There is evidence for 
an ATP-dependent GSSG translocase in erythrocytes (33) and 
a GSSG-stimulated ATPase in the plasma membrane fraction of 
rat liver (34,35). 
Thiol-disulfide exchange between reactive sulfhydryls 
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of proteins and low molecular weight thiols by the 
following reaction has been suggested as a major mechanism 
Protein-SH + GSSG . Protein-S-SG + GSH 
of protein S-thiolation. A negative correlation between 
GSH/GSSG ratio and protein S-thiolation has been observed 
suggesting that as the cellular glutathione pool becomes 
oxidized, protein S-thiolation increases (25,36). However, 
in vitro protein S-thiolation by GSSG required a rather 
high concentration of GSSG (37,38), and intracellular 
glutathione is not ordinarily oxidized to that extent even 
under oxidative stress (36,39,40). The involvement of 
enzymatic catalysis to thiol-disulfide exchange mechanism 
for protein S-thiolation is unlikely (21). Therefore, we 
proposed an alternative mechanism of protein S-thiolation 
which did not require oxidation of glutathione prior to 
protein S-thiolation in Section I of this dissertation. 
Although the physiological significance of protein S-
thiolation is not yet fully understood, early works 
suggested that glutathione bound to proteins might serve as 
an emergency pool of glutathione which could be mobilized 
according to cell's needs (7). More recent studies have 
suggested that protein S-thiolation can modulate catalytic 
activities of enzymes (6,41). The evidence for regulation 
of metabolic processes by oxidation and reduction of enzyme 
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thiols is convincing for oxygenic photosynthetic systems 
(42). In chloroplasts, electrons from chlorophyll are 
transferred to thioredoxin via ferredoxin and the reduced 
thioredoxin then modulates the activities of key enzymes. 
Well studied enzymes are malate dehydrogenase (43,44) and 
fructose-1,6-bisphosphatase (45,46). However, arguments 
for the possible regulatory role of reversible protein S-
thiolation in vertebrates are controversial, because 
crucial evidence for changes in the S-thiolation state of 
essential cellular proteins in response to physiological 
stimuli such as hormones which normally modulate metabolic 
reactions has not yet been clearly demonstrated (21). 
Sulfhydryl groups are essential for the activity of 
many enzymes, and most of the enzymes investigated were 
inhibited by S-thiolation. However, some enzymes are 
activated by S-thiolation, and these unexpected results led 
to the assumption that protein S-thiolation may have a 
regulatory role in the cellular metabolism. Enzymes known 
to be regulated by S-thiolation have been reviewed in 
several papers (21,41,47). Even though the evidence for 
the contribution to physiological metabolic regulation is 
meager, S-thiolation of certain enzymes may play an 
important role in defense against oxidative stress. The 
best characterized example for this hypothesis is the shift 
of carbohydrate metabolism from glycolysis to pentose 
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phosphate pathway for generation of reducing power NADPH. 
Glucose-6-phosphate dehydrogenase, a key enzyme in pentose 
phosphate pathway is known to be activated by S-thiolation 
(48,49), on the other hand, phosphofructokinase, a key 
enzyme in glycolysis is inhibited by S-thiolation 
(6,47,50), thus, glucose metabolism may be shifted for 
production of reducing power rather than energy to overcome 
prooxidant/antioxidant balance. Stimulation of the pentose 
phosphate pathway was observed in paraquat-treated lung 
slices with no or a decreased activity of glycolysis 
(49,51). This suggests that the shift to pentose phosphate 
pathway may occur in vivo during the oxidative stress. 
We have addressed another possible role of protein S-
thiolation in Section I. Since protein S-thiolation is 
reversible, and it seems that reactivity of protein 
sulfhydryls with oxyradicals is far greater than that of 
other amino acid functional groups, it is very likely that 
protein S-thiolation protects proteins from irreversible 
oxidative damage. In addition, cells seem to have very 
high capacity for reduction of S-thiolated proteins as 
shown in Sections II and III. 
Dethiolation 
Dethiolation (reduction of S-thiolated proteins) is 
very important for cells to recover from oxidative stress. 
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The results from our previous study with primary heart cell 
cultures treated with diamide, a thiol oxidizing agent, 
demonstrated that S-thiolated proteins were very actively 
dethiolated (20). Therefore, cells seem to have very 
efficient mechanisms for dethiolation. 
It has been suggested that dethiolation is also 
determined by thiol/disulfide ratio so that S-thiolated 
proteins can be dethiolated by an excess of GSH 
(21,38,47,52,53). Unlike S-thiolation, dethiolation by GSH 
can be catalyzed by enzymes. An enzyme known to catalyze 
the dethiolation by GSH is thioltransferase (54,55). This 
enzyme showed very broad specificity (56-59), it cleaved 
low molecular weight disulfides, protein mixed-disulfides 
(S-thiolated proteins), and intra- and inter-molecular 
protein disulfides. This enzyme was originally called 
glutathione-homocystine transhydrogenase, and also called 
thiol-disulfide oxidoreductase. Thioltransferase purified 
from rat liver is a basic protein with isoelectric point 
9.6, has a molecular weight of 11,000, and contains 8.6% 
(w/w) carbohydrate (56). Thiol-protein disulfide 
oxidoreductase (EC 1.8.4.2), also known as glutathione-
insulin transhydrogenase, is another enzyme catalyzing 
reduction of protein disulfide by GSH (53,60). This enzyme 
is known to be membrane-associated protein (61) and 
catalyzes reduction of a wide variety of disulfide bonds in 
8 
either low molecular weight thiols and or proteins in 
vitro. Substrates include insulin, oxytocin, ribonuclease, 
and choleratoxin (62,63). The enzyme is known to be 
ubiquitous both at the tissue (64) and subcellular level 
(65), and the enzyme purified from bovine liver is a 
glycoprotein with a molecular weight of 60,000 (66). A 
study with the human fibroblast enzyme shows that activity 
was influenced by growth conditions, being lower in serum-
deprived cells (61). A greater activity was found in 
tissues actively synthesizing procollagen (67). The 
physiological role of this enzyme is not yet understood, 
however, involvement in hormone inactivation (68) and in 
protein synthesis has been suggested (67). Another enzyme 
designated protein-disulfide isomerase (EC 5.3.4.1) 
catalyzes the reactivation of randomly oxidized and 
incorrectly disulfide bonded (scrambled) ribonuclease (69). 
This enzyme is suggested to be involved in the formation of 
native three-dimensional structure during biosynthesis of 
disulfide-bonded proteins (69-71). Currently, it is well 
accepted that thiol-disulfide oxidoreductase (EC 1.8.4.2) 
and protein-disulfide isomerase (EC 5.3.4.1) are identical 
proteins (72-74). 
Glutaredoxin was originally discovered in a mutant of 
Escherichia coli (tsnC 7004) lacking detectable thioredoxin 
but with a fully active NADPH-dependent ribonucleotide 
9 
reduction (75-78). Glutaredoxin has been purified from 
wild type E_^ coli B cells and it is a heat-stable small 
protein with a molecular weight of 11,600 and an acidic 
isoelectric point (79). Glutaredoxin is required for GSH-
dependent synthesis of deoxyribonucleotides (dNDPs) from 
ribonucleotide by the enzyme ribonucleotide reductase 
(80,81). In addition, glutaredoxin is capable of reducing 
some disulfides (82). The primary structure of coli 
glutaredoxin shows that it has two cysteine residues 
located at 11 and 14 in the polypeptide chain (83). 
Glutaredoxin was also purified from calf thymus. It 
behaved as a neutral or slightly basic molecule having a 
molecular weight of around 11,000, and had two cysteine 
residues, two amino acids apart in the active site (82). 
The amount of sequence similarity between pig liver 
thioltransferase and calf thymus glutaredoxin was 82% (84). 
An immunological study using polyclonal antibodies raised 
against pig liver thioltransferase showed that these 
antibodies completely neutralized the thioltransferase 
activity and also cross-reacted equally with calf thymus 
glutaredoxin and calf liver thioltransferase, but not with 
E. coli thioredoxin, suggesting that thioltransferase and 
glutaredoxin from the same species might be identical 
proteins (85). 
Thioredoxin was originally isolated from coli (86), 
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and characterized as a hydrogen donor for ribonucleotide 
reductase, an essential enzyme that forms the 
deoxyribonucleotide precursors of DNA from corresponding 
ribonucleotides and NADPH. Thioredoxin is present in many 
different procaryotes and eucaryotes. Thioredoxin from E. 
coli has molecular weight of 12,000 and isoelectric point 
at 4.5 (87). Thioredoxin has two "vicinal" cysteine 
residues in the sequence Trp-Cys-Gly-Pro-Cys-Lys (88). 
Thioredoxin functions as a hydrogen donor for enzymes such 
as ribonucleotide reductase, methionine sulfoxide 
reductase, and sulfate reductase (89-93). Thioredoxin is 
also known to be a protein disulfide reductase implicated 
in degradation of insulin (94). The reduced form of 
thioredoxin reduces protein disulfides, then oxidized 
thioredoxin is reduced by NADPH and thioredoxin reductase 
(95). In chloroplasts of plants, two forms of thioredoxin 
(f and m) regulate the activity of photosynthetic enzymes 
like fructose-1,6-bisphosphatase and malate dehydrogenase 
by light (96-100). This process is coupled to reduction of 
thioredoxin by electrons from ferredoxin catalyzed by a 
special enzyme, ferredoxin-thioredoxin reductase, generally 
present in oxygenic photosynthetic cells. In mammalian 
cells, it has been demonstrated that thioredoxin is an 
activating factor for glucocorticoid receptor (101,102), 
and involvement of thioredoxin in regulation of coagulation 
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factor activity (103) and control of initiation in protein 
synthesis (104) were implicated. However, the 
physiological roles of thioredoxin in mammalian cells are 
still largely uncharacterized. A study of tissue 
distribution and subcellular localization of calf liver 
thioredoxin using rabbit antiserum showed that thioredoxin 
was present in homogenates of nuclei, mitochondria, 
microsomes, and in the 100,000xg postmicrosomal 
supernatant, and a fraction of thioredoxin was associated 
with membranes (105). However, study with different organs 
and tissues indicated that different cell types showed 
large variations in immunoreactivity. Hepatocytes, 
different epithelial and secretory cells, plasma cells, and 
neurons had high content of thioredoxin. In contrast, 
mesenchymal cells of connective tissue, bone, muscle, and 
fibrous tissue generally showed a low or no 
immunoreactivity. Furthermore, variations in the content 
of immunoreactive thioredoxin in non-proliferating, 
differentiated cells were related to their metabolic 
activity, accumulated cell products, and secretory 
processes (106). Therefore, the content of thioredoxin 
seems to be regulated by metabolic activities. 
We examined the dethiolation of S-thiolated proteins, 
a process of disulfide reduction, by thioredoxin using 
recombinant E. coli thioredoxin in Section II. In section 
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III, possible mechanisms of dethiolation by GSH and NADPH-
dependent processes were investigated. 
Oxidative stress 
Oxidative stress denotes oxidative damage to cellular 
constituents by reactive oxygen species. Involvement of 
oxidative stress in aging and various diseases including 
carcinogenesis is suggested (107). Reactive oxygen 
species, such as superoxide anion (O2), hydrogen peroxide 
(H2O2), and hydroxyl radical (-OH) are generated by one 
electron reduction of molecular oxygen as shown below. 
Oxygen centered organic radicals, alkoxy radical (RO-), 
e" e" e" e" 
O2 O2 H2O2 -OH H2O 
peroxy radical (ROO•), organic hydroperoxide (ROOH), and 
singlet oxygen (^O^) are also generated by similar 
pathways. The term oxyradicals is used more or less 
synonymously with reactive oxygen species even though 
hydrogen peroxide is not a radical species (108). 
Cells have a number of highly efficient antioxidant 
defense systems which can protect from the potentially 
harmful effects of oxyradicals. These defense mechanisms 
include enzymatic removal of oj by superoxide dismutase, 
and of H2O2 by catalase and glutathione peroxidase (109-
111). Superoxide dismutase exists in two major forms, a 
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copper zinc containing enzyme in cytoplasm and a manganese 
containing enzyme in mitochondria (112). This enzyme 
catalyzes the dismutation of oj to yield H2O2 and O2. 
2 oj + 2 H"*" HgOg + Og 
Catalase is a hemeprotein and catalyzes the decomposition 
of H2O2 to yield O2 and H2O. This enzyme is present in 
2 H2O2 ' O2 + 2 H2O 
peroxisomes which are present in most tissues. Catalase is 
specific for H2O2 and does not decompose organic 
hydroperoxides. Glutathione peroxidase, a selenium 
containing enzyme, catalyzes decomposition of both H2O2 and 
organic peroxides at the expense of GSH (113). This enzyme 
2 GSH + H202(R00H) •- GSSG + HgO + H20(R0H) 
is found in most tissues in the cytoplasm, nuclei, and 
mitochondria. 
There are also nonenzymatic oxyradical scavengers such 
as cr-tocopherol, 6-carotene, vitamin A, ascorbate, and low 
molecular weight thiols (109). Various histidine 
derivatives have been suggested to function as antioxidants 
(114). 
Oxyradicals are produced either by normal 
physiological processes or by exogenous species. Of all 
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the oxyradicals formed in biological systems, the most 
attention has been focused on superoxide anion (O^), the 
species formed when oxygen is reduced by a single electron 
(115,116). Superoxide dismutase has provided a tool that 
permits testing the involvement of superoxide anion. 
Unexpectedly, superoxide anion found to be formed in all 
aerobically metabolizing normal cells (115). For example, 
superoxide anion appears to leak out of mitochondria (117). 
The principal site of leakage seems to be the NADH-coenzyme 
Q reductase complex (107). The endoplasmic reticulum of 
many animal and some plant tissues contains a special 
cytochrome known as cytochrome P^gg. Cytochrome P450 is 
involved in the oxidation of wide range of substrates at 
the expense of molecular oxygen. In liver, the electrons 
AH + O2 + RHg AOH + R + HgO 
AH: substrate 
RH2: reducing agent (e.g., NADPH) 
required by the P450 system are donated by NADPH via 
flavoprotein enzyme NADPH-cytochrome P450 reductase (107). 
The reduced form of NADPH-cytochrome P45Q reductase is 
known to be capable of reducing oxygen to give O^. In 
addition, there is some evidence that the oxygenated 
intermediates of cytochrome P450 itself can decompose in a 
minor side reaction and release oj. Indeed, isolated 
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microsomal fractions from various tissues have been shown 
to produce superoxide anion. Prostaglandin H synthase 
catalyzes the conversion of arachidonic acid to 
prostaglandin endoperoxides. The enzyme has two distinct 
enzymatic activities, i.e., the fatty acid cyclooxygenase 
converts arachidonic acid to the hydroperoxy endoperoxide, 
prostaglandin G2, whereas hydroperoxidase reduces the 
hydroperoxy group of prostaglandin G2 to the corresponding 
alcohol forming prostaglandin H2 (118). Because the 
hydroperoxidase reaction is a single electron oxidation, 
intermediates of the reaction are free radicals. Free 
radical species generated by this enzyme has been detected 
in in vivo and in vitro studies (119,120). Macrophages and 
neutrophils produce superoxide anion by NADPH oxidase 
reaction during the oxidative burst that follows their 
activation (121,122). 
Oxyradicals are also produced by the influence of 
exogenous species. These exogenous species may be 
compounds that occur naturally in the biosphere (e.g., 
ozone, NO2, and ethanol), industrial chemicals (e.g., 
CCI4), or xenobiotics. Well characterized oxyradical 
generating xenobiotics are guinone compounds such as 
adriamycin and menadione that undergo redox-cycling (123). 
Another enzyme known to generate oxyradicals is 
xanthine oxidase. It was proposed that xanthine oxidase 
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might play a pivotal role in oxyradical production on 
reperfusion of ischemic myocardium (109,124,125). The 
mechanism depends on the proteolytic cleavage (124,126) or 
oxidation (127,128) of native enzyme, xanthine 
dehydrogenase which transfers electrons from substrate to 
NAD"*", to xanthine oxidase which transfers electrons to 
molecular oxygen (129-131). Xanthine oxidase then 
catalyzes the oxidation of hypoxanthine or xanthine to 
xanthine or urate, generating superoxide anion or hydrogen 
peroxide depending on the oxidation state of the enzyme 
(132-135). At the moment of reperfusion with O2, the 
reaction would be expected to proceed rapidly in the 
presence of accumulated purine nucleotides (hypoxanthine 
and xanthine) (136) and xanthine oxidase. 
Oxyradicals are extremely reactive and different forms 
of oxyradicals can be generated from one another. For 
example, superoxide anion undergoes dismutation reaction to 
form hydrogen peroxide, and hydroxyl radical can be formed 
from the following sequence of reaction (107). 
Fe3+ + oj Fe2+ + O, 
Fe^ + H2O2 ' Fe^ + "OH + 0H~ (Fenton reaction) 
_ Fe-salt 
Net: O2 + H2O2 O2 + "OH + OH" (iron-catalyzed 
catalyst Haber-Weiss reaction) 
Therefore, in many cases, greater protection against 
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oxidative damage is observed with combinations of different 
oxyradical scavengers. 
Oxyradicals damage virtually all types of 
biomolecules. Oxyradicals attack purine and pyrimidine 
bases and sugar moieties of DNA causing strand breakage 
(137,138). It is well known that exposure of biological 
membranes to oxidative stress results in progressive 
degeneration of membrane structure and loss of activity 
(139). It is generally accepted that the membrane 
degeneration is due to lipid peroxidation of membrane 
lipids containing polyunsaturated fatty acids (139). 
The importance of damage to amino acids in proteins 
during oxidative stress has recently been recognized. 
Methionine can be oxidized by oxyradicals to sulfoxide and 
further to sulfone (140). The involvement of methionine 
oxidation in inhibition of several proteins has been 
observed, e.g., oxidation of methionine-358 at the active 
site of o^-antitrypsin dramatically decreases inhibitory 
activity toward elastase (141). The loss of regulation of 
elastase is thought to be responsible for the development 
of pulmonary emphysema (142). Histidines are also easily 
damaged by oxyradicals. The involvement of oxidation of 
histidines in glutamine synthase from E^. coli in inhibition 
of this enzyme during oxidative stress and a subsequent 
increase in proteolytic degradation is well documented 
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(143-146). The products of hlstidine oxidation have not 
yet been identified. Oxidative ring opening of proline has 
been suggested as a mechanism of polypeptide fragmentation 
(147). Collagen which is proline rich was found to be 
particularly susceptible to oxidative stress (148). 
Tryptophane, lysine, and tyrosine are also subject to 
oxidative damage (137). Cysteine is also oxidized to 
inactive form such as sulfenic, sulfinic, and finally 
sulfonic acids (149,150). Therefore, a reversible thiol 
modification, e.g., protein S-thiolation, is of great 
interest in protecting proteins from irreversible oxidative 
damage. 
Methodoloav 
The methods previously used for determination of 
protein S-thiolation and dethiolation were based on the 
quantitation of thiols released from proteins by reducing 
agents (41). These methods could not be used for the 
analysis of S-thiolation of individual proteins in reaction 
mixture, and often caused variability due to incomplete 
removal of the protein prior to determination. Therefore, 
a new method for the assay of protein S-thiolation and 
dethiolation was developed by our laboratory using 
electrofocusing (151). This method requires small amounts 
of protein and it can be used for more than one protein in 
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a same reaction mixture. After reaction, protein samples 
are derivatized with either iodoacetamide or iodoacetic 
acid to block free protein sulfhydryls. This method can be 
used to determine if the protein is S-thiolated with thiols 
such as glutathione, cysteamine, or cysteine. S-thiolation 
with charged thiols (glutathione or cysteamine) changes the 
protein net charge and the protein focuses at a different 
position. Proteins S-thiolated with uncharged thiols 
(cysteine) can be differentiated from the reduced form of 
protein by alkylating with iodoacetic acid to give negative 
charge to unmodified protein sulfhydryls. 
In this dissertation, two proteins, creatine kinase 
and glycogen phosphorylase b, were chosen for substrate 
proteins. These two proteins could be obtained in very 
pure forms after further purification and they focused well 
on electrofocusing gels. These two proteins are very 
actively S-thiolated and subsequently dethiolated during 
oxidative stress in cardiac cells. 
20 
Explanation of dissertation format 
This dissertation follows an alternate format. The 
main portion of this dissertation is composed of three 
sections, the study of mechanism of protein S-thiolation is 
presented in Section I and the study of mechanism of 
dethiolation is presented in Sections II and III. 
All experiments were performed by the author with 
helpful advice and discussion from Dr. James A. Thomas. 
Entire manuscripts were prepared by the author with 
discussion with Dr. James A. Thomas. The paper of Section 
I was published in Biochimica et Biophysica Acta, volume 
964 (1988), pages 151-160, the paper of Section II was 
accepted by Archives of Biochemistry and Biophysics for 
publication in July, 1989, and the paper of Section III was 
accepted by Archives of Biochemistry and Biophysics for 
publication. 
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SECTION I. S-THIOLATION OF 
PHOSPHORYLASE b 
OXYGEN SPECIES 
CREATINE KINASE AND GLYCOGEN 
INITIATED BY PARTIALLY REDUCED 
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S-Thiolation of Creatine Kinase and 
Glycogen Phosphorylase b Initiated by 
Partially Reduced Oxygen Species 
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ABSTRACT 
S-thiolation of cardiac creatine kinase and skeletal 
muscle glycogen phosphorylase b was initiated by reduced 
oxygen species in reaction mixtures containing reduced 
glutathione. Both proteins were extensively modified at 
similar rates under conditions in which the oxidation of 
glutathione was inadequate to cause S-thiolation by thiol-
disulfide exchange. Creatine kinase was both S-thiolated 
and non-reducibly oxidized at the same time at low 
glutathione concentration. The amount of each modification 
was decreased by adding additional reduced glutathione and 
with adequate glutathione, oxidation was prevented while S-
thiolation was still very active. S-thiolation of glycogen 
phosphorylase b was not significantly affected by 
glutathione concentration and non-reducible oxidation of 
glycogen phosphorylase b was not observed. These 
experiments suggest that oxyradical- or H202-initiated 
processes may be an important mechanism of protein S-
thiolation during oxidative stress, and that the cellular 
concentration of glutathione may be an important factor in 
S-thiolation of different proteins. 
Both creatine kinase and glycogen phosphorylase b 
competed favorably with ferricytochrome c for superoxide 
anion in the standard xanthine oxidase system for 
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generation of oxyradicals and H2O2. These proteins were as 
effective as ascorbate and much more effective than 
reduced glutathione in this regard. Ascorbate was also an 
effective inhibitor of oxyradical-initiated S-thiolation of 
creatine kinase, suggesting a role of superoxide anion in 
protein S-thiolation. Other experiments showed that both 
catalase and superoxide dismutase could partially inhibit 
protein S-thiolation. Thus, reduced oxygen species may 
react with protein sulfhydryls resulting in S-thiolation by 
a mechanism that involves the reaction of an activated 
protein thiol with reduced glutathione. 
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INTRODUCTION 
Oxyradicals and HgOg can directly react with proteins 
by several mechanisms (1,2), an effect that may be 
important in radical-mediated cytotoxicity. Amino acids 
such as cysteine (3), methionine (4), tryptophan (5), 
histidine, tyrosine, and proline (2) are considered 
potential sites for reaction. Some of the resulting 
protein modifications may be irreversible and initiate 
protein degradation (6,7). On the other hand, protein S-
thiolation (formation of mixed-disulfides between 
glutathione and protein sulfhydryls) is a reversible 
modification that can be initiated by oxyradicals (3) and 
may be of significance in metabolic regulation (8-10) 
during oxidative stress. S-thiolation may have major 
effects on several cellular activities, such as membrane-
associated calcium pumping activity (11,12), NADPH 
production by pentose phosphate pathway (10), or proton 
conductivity and ATPase activity (13). Each of these 
processes may be directly related to the toxic effects of 
oxidative stress. 
S-thiolation of proteins by a thiol-disulfide exchange 
mechanism in which glutathione disulfide (GSSG) reacts with 
the reduced protein to form S-thiolated protein has been 
suggested as a major mechanism of protein S-thiolation 
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in vivo (8,9,14). The reaction has been shown to be 
rather specific for certain reactive sulfhydryls and the 
amount of protein adduct formed is determined by the 
thermodynamic equilibrium state of the protein and 
glutathione thiol/disulfide redox couples (9,15). The rate 
of this process is frequently quite slow, and the evidence 
for enzymatic catalysis is meager. In addition, 
glutathione does not ordinarily become oxidized to the 
extent that protein S-thiolation could occur in vivo (16-
18). A more feasible mechanism for the formation of S-
thiolated proteins in vivo might involve an oxyradical- or 
H2O2-initiated mechanism. This process involves a direct 
reaction between a reduced protein sulfhydryl, reduced 
glutathione, and some partially reduced oxygen species. 
This reaction does not require enzymatic catalysis or 
extensive oxidation of cellular glutathione, and it might 
occur at localized sites in close proximity to the site of 
oxyradical or ^ 2^2 generation. Thus, protein S-thiolation 
and glutathione oxidation (19) could be two competing 
processes, each of which might occur by direct reaction 
with oxyradicals. 
It is possible to directly study protein S-thiolation 
by an electrofocusing method (20) and the present report 
explores the reaction of two soluble proteins with reduced 
oxygen species generated by xanthine oxidase. This study 
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shows that protein S-thiolation occurs under conditions 
that may account for a selective and extensive S-thiolation 
of reactive protein sulfhydryls in cells under oxidative 
stress. 
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MATERIALS AND METHODS 
Materials 
Rabbit muscle glycogen phosphorylase b, xanthine 
oxidase (grade III), horse heart ferricytochrome c (type 
III), reduced glutathione and glutathione disulfide, 
iodoacetamide, iodoacetate, and PMSF were obtained from 
Sigma Chemical Company, St. Louis, MO, U.S.A. Ampholytes 
were from LKB-produkter AB, Bromma, Sweden. GelBond was 
from FMC Corp., Rockland, ME, U.S.A. Affigel Blue was from 
Bio-Rad, Richmond, CA, U.S.A. Sephacryl S-200 and Sephadex 
G-200-40, were from Pharmacia Fine Chemicals, Piscataway, 
NJ, U.S.A. 
Purification of creatine kinase 
Creatine kinase was purified from bovine heart by 
methods similar to Hershenson et al. (21). Cardiac tissue 
proteins were S-thiolated with 10 mM glutathione disulfide 
at an early step of purification to prevent oxidative 
damage to reactive sulfhydryls. Frozen heart tissue was 
homogenized in 2 volumes of 20 mM ^-glycerophosphate, 5 mM 
EDTA, 5 mM EGTA, 0.1 mM PMSF, pH 7.0, and centrifuged at 
10,000xg for 45 minutes at 4°C. The precipitate was 
discarded and the supernatant was filtered through glass 
wool. The protein was precipitated with 50-70% cold 
ethanol, and dissolved in buffer (20 mM B-glycerophosphate, 
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5 mM EDTA, 5 mM E6TA, 0.1 mM PMSF, pH 7.5) containing 10 mM 
glutathione disulfide and kept overnight at 4°C. This step 
resulted in S-thiolation of reactive sulfhydryl groups. 
The solution was dialyzed against 10 mM MES, 40 mM NaCl, pH 
6.0 for five hours, and was applied to an Affigel Blue 
column equilibrated with the same buffer. The column was 
washed with the buffer and the protein was eluted with 10 
mM 6-glycerophosphate, 40 mM NaCl, pH 6.8. The peak 
fractions (280 nm) were collected, concentrated and 
dialyzed by Amicon filtration (YM-10 membrane), and applied 
to a Sephacryl S-200 column equilibrated with 20 mM 6-
glycerophosphate, pH 7.0. Fractions containing S-thiolated 
creatine kinase were identified by electrofocusing, pooled, 
and concentrated for further purification by preparative 
electrofocusing. The concentrated S-thiolated fraction was 
applied to a thin bed of Sephadex G-200-40 containing 2% 
w/v preblended pH 5-8 LKB ampholyte on GelBond for agarose 
as described by Allen et al. (22). The proteins were 
focused for 50 minutes at 1500 V and the band containing S-
thiolated creatine kinase was eluted with 20 mM 6-
glycerophosphate, pH 7.0 buffer. Purified S-thiolated 
creatine kinase was reduced with 10 mM dithiothreitol in 
the presence of 2 mM EDTA for 30 minutes at 30°C to 
regenerate the reduced protein sulfhydryls and to chelate 
contaminating cations. Both dithiothreitol and EDTA were 
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removed by dialysis against 20 mM B-glycerophosphate pH 7.0 
and 30% glycerol was added. The purified creatine kinase 
was stored at -20®C. 
Preparation of alvcoaen phosphorvlase b and xanthine 
oxidase 
Glycogen phosphorylase b was treated with 5 mM 
dithiothreitol, 2 mM EDTA, 20 mM B-glycerophosphate, pH 7.0 
for 30 minutes at 30°C and dialyzed against 20 mM B-
glycerophosphate, pH 7.0. Xanthine oxidase was treated 
with 1 mM PMSF and 2 mM EDTA overnight at 4°C to remove 
contaminating protease activity, and then dialyzed against 
20 mM B-glycerophosphate, pH 7.0, and stored at -20°C in 
small aliguots sufficient for individual experiments. 
Untreated xanthine oxidase in which the contaminating 
protease was not inactivated produced additional bands of 
degraded protein in electrofocusing experiments. 
Analysis of protein S-thiolation 
S-thiolation of creatine kinase and glycogen 
phosphorylase b was analyzed by thin-gel electrofocusing as 
described previously (20). Protein samples were applied to 
the gel after alkylation with either 40 mM iodoacetamide or 
sodium iodoacetate for at least 15 minutes in 6-
glycerophosphate buffer, pH 7.0. Polyacrylamide gels with 
4% T-2.6% C containing either 2% LKB Ampholytes, a mixture 
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of 1 volume of 3.5-10 with 3.6 volume of 5-8 Ampholytes, 
for glycogen phosphorylase b, or 2% preblended LKB pH 5-8 
Ampholyte for creatine kinase were used. Gels were 
prefocused for 10 minutes, samples were applied in 
applicator strips (Serva Fine Biochemicals, Inc.) 
approximately 1.5 cm from the anode, and then focused for 
50 minutes at 4°C. The limiting voltage was 1500 V and the 
limiting current was 2.8 mA/cm gel width. Gels were 
stained as described (20). 
Other analyses 
Glutathione was analyzed by a modification of the HPLC 
method of Reed et al. (23). Five percent perchloric acid 
and 2.5 mM o-phenanthroline were added to the samples to 
avoid artifactual oxidation of glutathione during 
treatment. Acid-soluble compounds were dérivâtized with 1-
fluoro-2,4-dinitrobenzene as described previously (24). 
Superoxide anion was assayed by reduction of 
ferricytochrome c as described by Johnston (25). 
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RESULTS 
S-Thiolation of cardiac creatine kinase bv an oxvradical-
or HgO^zinitiated process 
Oxidative effects on soluble proteins were generated 
by xanthine oxidase with sufficient xanthine to insure a 
continuous reaction throughout the entire experiment. It 
was established that uric acid was continuously generated 
for at least 60 minutes under our reaction conditions. 
Effects of oxyradicals could be quantitated by density 
scanning of the protein bands observed. 
Figure I-l shows an experiment on the S-thiolation of 
the MM isoenzymic form of bovine cardiac creatine kinase as 
analyzed by thin-gel electrofocusing. The protein was S-
thiolated by thiol-disulfide exchange with glutathione 
disulfide (Figure I-IA) and by a xanthine oxidase-initiated 
process (Figure I-IB). Lane 1 in Figure I-IA shows that 
reduced creatine kinase migrated as a single band with pi 
of 6.4 when alkylated with iodoacetamide (band a). 
Alkylation with iodoacetamide insured that reactive 
sulfhydryl groups did not ionize during focusing and 
thereby, affect the protein analysis. Lane 2 shows the 
position (pi 6.2, band c) for fully S-thiolated creatine 
kinase, i.e., two sulfhydryl groups modified per dimer. 
Partial S-thiolation of reduced protein by thiol-disulfide 
exchange produced two acidic forms of the protein (lane 3). 
Figure 1-1. S-thiolation of creatine kinase by (A) thiol-
disulfide exchange and by (B) an oxyradical- or 
HgOg-initiated process. 
(A). Lane 1 (band a) shows reduced creatine kinase 
alkylated with iodoacetamide as described in 
Materials and Methods (pi 6.4). Lane 2 shows 
reduced creatine kinase alkylated with iodoacetate 
which migrates identically with fully S-thiolated 
creatine kinase (pi 6.2, band c). In lanes 3-6, 
creatine kinase was incubated with 2 mM glutathione 
disulfide at pH 7.0 for 5 minutes at 37°C to 
partially S-thiolate the protein. Samples in lanes 
5 and 6 were treated with 10 mM dithiothreitol for 
20 minutes at 37°C after the reaction with 
glutathione disulfide. The reaction was stopped 
with either 40 mM iodoacetamide or 40 mM iodoacetate 
as indicated in the figure. 
(B). Creatine kinase was incubated for 20 minutes 
at 37°C with 1.5 mM xanthine and 33 munit/ml 
xanthine oxidase at pH 7.2 either with 0.3 mM GSH 
(lanes 7-10) or without GSH (lanes 11-14). Samples 
in lanes 9, 10, 13, and 14 were treated with 10 mM 
dithiothreitol for 20 minutes at 37°C after the 
initial reaction, and before alkylation with either 
40 mM iodoacetamide or 40 mM iodoacetate as 
indicated in the figure. Abbreviations: IAM, 
iodoacetamide; lAA, iodoacetate; DTT, 
dithiothreitol; GSH, reduced glutathione; GSSG-
glutathione disulfide. Band a, pi 6.4; band b, pi 
6.3; band c, pi 6.2 
A. B. 
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These forms contained a single modified sulfhydryl group 
(band b) or two modified sulfhydryl groups (band c) per 
dimer. When the partially S-thiolated protein (lane 3) was 
treated with iodoacetate, only free sulfhydryls were 
alkylated and all of the protein migrated with the same pi 
as the fully S-thiolated form of creatine kinase (lane 4). 
The same protein sample analyzed in lanes 3 and 4 was first 
reduced and then alkylated with either iodoacetamide (lane 
5) or iodoacetate (lane 6). This reduced protein sample 
focused as though all reactive sulfhydryl groups were free 
(compare lanes 1 and 2 with lanes 5 and 6). These results 
show that S-thiolation of creatine kinase by thiol-
disulfide exchange with glutathione disulfide specifically 
S-thiolates two reactive sulfhydryl groups on cardiac 
creatine kinase. These protein forms were completely 
reduced by dithiothreitol. 
Figure I-IB shows the xanthine oxidase-initiated 
reaction with creatine kinase either in the presence or 
absence of reduced glutathione. Lane 7 shows that four 
protein bands with more acidic pi values than the reduced 
form of creatine kinase (band a) were produced in the 
presence of reduced glutathione. The bands designated b 
and c corresponded to the S-thiolated bands shown in Figure 
I-IA, lane 3. When the oxyradical- or H202-altered 
creatine kinase was alkylated with iodoacetate (lane 8), 
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most of the protein migrated at pi 6.2, identically to the 
fully S-thiolated protein. Approximately 19% of the 
protein migrated with a more acidic pi. This fraction of 
the protein probably contains at least one additional 
modified amino acid that is not identical to the reactive 
sulfhydryl groups that become S-thiolated. On reduction 
and alkylation of oxyradical- or HgOg-altered creatine 
kinase with either iodoacetamide or iodoacetate, most of 
the protein migrated as though it was reduced creatine 
kinase (see lanes 9 and 10). Again, a small fraction of 
the protein migrated as though it had additional negative 
charge. The majority of this altered protein migrated 
identically to the S-thiolated form of creatine kinase 
designated by band b on this gel. Therefore, a majority of 
the protein that contained additional non-reducible charge 
changes appeared to have a single additional negative 
charge per dimer. Lanes 11-14 show that when creatine 
kinase was incubated without glutathione, a molecular 
species with a pi of 6.2 and a minor band at more acidic pH 
were produced. These proteins could not be alkylated with 
iodoacetamide or iodoacetate and modification was not 
reversed by simple reduction. This result suggests that in 
the absence of glutathione a modification of the reactive 
sulfhydryl group converts this amino acid into an oxidized 
species that is charged and cannot be reduced by 
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dlthiothreitol. During exposure of creatine kinase to 
reduced oxygen species, glutathione protected the reactive 
sulfhydryl by forming an S-thiolated species that was fully 
reduced by dithiothreitol. 
The reducible and non-reducible modification of 
creatine kinase was guantitated by densitometry. For this 
purpose each band in Figure I-l that was designated with an 
arrow was quantitated. The band labeled b (pi 6.3) was 
considered to result from the addition of one negative 
charge to the dimeric protein and band c (pi 6.2) from two 
additional charges. The two bands with pi less than 6.2 
were assumed to result from either one or two additional 
negative charges. Gel densitometry was quantitated as 
follows. First, the total charge change in the substrate 
protein was obtained from samples treated as in lane 7 of 
Figure I-l. The density of each protein band was 
multiplied by the total charge change attributed to the 
position of the band, e.g., band b was multiplied by one, 
band c by two, the next acidic band by 3, and the most 
acidic band by 4. These weighted densities were summed to 
obtain the total charge change. Second, the non-reducible 
modification in the protein was quantitated from samples 
treated as in lane 9 in a similar manner. Finally, the 
non-reducible charge change was subtracted from the total 
charge change to obtain the reducible change in the protein 
Figure 1-2. Effect of GSH on oxyradical- or H2O2-initiated 
charge changes in creatine kinase. 
Creatine kinase was incubated for 30 minutes at 37°C 
with 1.5 mM xanthine and 33 munit/ml xanthine 
oxidase at pH 7.2 in the presence of indicated 
amount of GSH. One aliquot of each reaction was 
alkylated with 40 mM iodoacetamide to stop the 
reaction and a second aliquot was treated with 10 mM 
dithiothreitol for 20 minutes at 37°C before 
alkylation with iodoacetamide. Electrofocusing gels 
were quantitated as described in the text and both 
non-reducible and reducible charge changes in the 
creatine kinase are shown 
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substrate. 
Figure 1-2 shows the effect of reduced glutathione 
concentration on both reducible and non-reducible change of 
creatine kinase when incubated with the xanthine oxidase 
system. At low glutathione, a considerable amount of non­
reducible protein modification occurred, but with 1 mM 
glutathione, only reducible modification (S-thiolation) was 
observed. Both reducible and non-reducible protein 
modification processes were inhibited by increasing the 
concentration of glutathione, but with 1 mM glutathione, 
there was still substantial protein S-thiolation. This 
experiment suggests that the effect of reduced oxygen 
species on the sulfhydryl groups of cardiac creatine kinase 
may be modulated by the glutathione concentration. S-
thiolation may be the exclusive modification when the 
supply of reduced glutathione is adequate. 
Protein S-thiolation initiated by reduced oxygen 
species could result from a thiol-disulfide exchange 
process in which reduced oxygen species directly oxidized 
glutathione and the glutathione disulfide then reacted with 
protein sulfhydryls to form the S-thiolated species. This 
possibility was eliminated by the experiments shown in 
Figures 1-3 and 1-4. Figure 1-3 shows the time course of a 
reaction in which both protein modification and glutathione 
oxidation were determined. Figure I-3A shows that both 
Figure 1-3. A comparison of oxyradical- or H2O2-initiated 
changes in creatine kinase (A) and oxidation of 
glutathione (B). 
Creatine kinase was incubated as in Figure 1-2 with 
0.3 mM GSH. 
(A). At the indicated time, one aliquot of the 
reaction was stopped by adding 40 mM iodoacetamide 
and second aliquot was treated with 10 mM 
dithiothreitol for 20 minutes at 37°C before adding 
40 mM iodoacetamide. Samples were analyzed as 
described for Figure 1-2. 
(B). At the indicated time, a third aliquot of the 
reaction was analyzed for reduced glutathione and 
glutathione disulfide 
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reducible and non-reducible modifications were produced 
during the entire reaction, although non-reducible 
modifications were minimal at early times. Figure I-3B 
shows that glutathione oxidation was not extensive and at 
no time was the concentration of glutathione disulfide 
higher than 50 pM. At this low concentration of 
glutathione disulfide, it was not likely that thiol-
disulfide exchange could contribute to the S-thiolation of 
creatine kinase. In lane 4, Figure 1-4, no more than 3% of 
the creatine kinase was S-thiolated under conditions in 
which glutathione was half oxidized. In lane 5 (containing 
150 pM glutathione disulfide and incubated for 30 minutes), 
only 26% of the creatine kinase was S-thiolated. Thus, the 
extensive S-thiolation observed in Figure I-l could not be 
attributed to glutathione oxidation with subsequent thiol 
exchange with the protein sulfhydryl groups. Moreover, an 
additional experiment showed that creatine kinase was not 
significantly S-thiolated by incubating the protein with 50 
joM glutathione disulfide in the presence of xanthine 
oxidase system. Thus, mechanisms involving glutathione 
disulfide-mediated protein S-thiolation were quantitatively 
insignificant. 
Figure 1-4. S-thiolation of creatine kinase by a low 
concentration of glutathione disulfide. 
Creatine kinase in lanes 1 and 2 was treated as in 
Figure I-l to show the positions of fully reduced 
and fully S-thiolated creatine kinase, respectively. 
In lanes 3-5, creatine kinase was incubated for 30 
minutes at 37°C with indicated amount of reduced 
glutathione and glutathione disulfide at pH 7.0. 
All samples were alkylated with 40 mM iodoacetamide 
before focusing 
Reduced 
Thiolated 
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S-Thiolation of alvcoaen phosphorvlase b 
Glycogen phosphorylase b contains two reactive 
sulfhydryl groups per subunit. Since it migrates as a 
dimer in thin electrofocusing gels, five bands were 
observed during S-thiolation experiments. The pi values 
ranged from 6.1 for the reduced protein to 5.8 for the 
fully S-thiolated protein. Figure 1-5 shows an analysis of 
the modification of this protein by the xanthine oxidase 
system. Lane 1 shows the reduced protein and lane 2 the 
fully S-thiolated protein. In the absence of reduced 
glutathione, xanthine oxidase initiated a significant 
modification of the protein (lane 3) and some of the 
modification was reversible by simple reduction (lane 4). 
The nature of these modifications was not explored further. 
In the presence of reduced glutathione, more extensive 
modification of the protein was observed (lane 5) and it 
was completely reversible by reduction with dithiothreitol. 
This observation is consistent with the S-thiolation of 
phosphorylase b by an oxyradical- or H202-initiated 
mechanism in the presence of glutathione. 
The time course of S-thiolation of phosphorylase b is 
shown in Figure 1-6. The protein modification was 
extensive after 60 minutes and it was fully reversible by 
simple reduction (lane 10). There was no evidence of a 
non-reducible modification as observed for creatine kinase. 
Figure 1-5. Effect of GSH on S-thiolation of glycogen 
phosphorylase b. 
Lane 1 is reduced glycogen phosphorylase b alkylated 
with 40 mM iodoacetamide and lane 2 is reduced 
glycogen phosphorylase b alkylated with 40 mM 
iodoacetate. Fully S-thiolated phosphorylase b 
focuses identically to lane 2. In lanes 3-6, 
glycogen phosphorylase b was incubated for 60 
minutes at 37°C with 1.5 mM xanthine and 33 munit/ml 
xanthine oxidase with and without GSH as in Figure 
1-2. Reactions were stopped by adding 40 mM 
iodoacetamide. Samples in lanes 4 and 6 were 
treated with 10 mM dithiothreitol for 20 minutes at 
37°C before alkylation (Reduced phosphorylase, pi 
6.1; S-thiolated phosphorylase, pi 5.8) 
Reduced 
Thiolated 
DTT DTT 
GSH +GSH 
0.5 mM 
Figure 1-6. Time course of S-thiolation of glycogen 
phosphorylase b. 
Lanes 1 and 2 are as in Figure 1-5. In lanes 3-10, 
glycogen phosphorylase b was incubated with 1.5 mM 
xanthine, 33 munit/ml xanthine oxidase and 0.1 mM 
GSH as in Figure 1-2. At the indicated time, 
aliquots were alkylated with 40 mM iodoacetamide to 
stop the reaction. After 60 minutes incubation, two 
aliquots were removed and one was treated with 10 mM 
dithiothreitol for 20 minutes at 37°C before 
alkylation 
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The amount of S-thiolation was verified by a second method 
that determined the amount of glutathione bound to the 
protein. A higher concentration of phosphorylase b was 
incubated under similar reaction conditions, and unreacted 
glutathione was dialyzed away. This phosphorylase b had an 
electrofocusing pattern like that in lane 9. The protein 
sample was reduced with dithiothreitol, and the released 
glutathione was determined as described earlier (26). The 
protein contained 2.4 glutathione molecules per dimer of 
phosphorylase b. Densitometric quantitation of the 
electrofocusing gel of this same protein sample gave 2.75 
S-thiolated sulfhydryl groups per dimer. Thus, it is clear 
that reduced oxygen species initiated protein S-thiolation 
when reduced glutathione was present in the reaction 
mixture. 
Figure 1-7 compares the progress curve for the S-
thiolation of phosphorylase b with that for oxidation of 
glutathione in the same reaction. There was more extensive 
oxidation of glutathione than in the similar experiment 
with creatine kinase (Figure 1-3), but the glutathione 
disulfide concentration was always less than 50 pM. In a 
separate experiment, reduced phosphorylase was incubated 
with 50 joM glutathione disulfide and no S-thiolation could 
be observed for 60 minutes. Thus, S-thiolation of 
phosphorylase b by an oxyradical- or H202-mediated 
Figure 1-7. A comparison of the rate of S-thiolation of 
glycogen phosphorylase b and the rate of 
oxidation of glutathione in oxyradical- or 
H2O2-initiated oxidation. 
Glycogen phosphorylase b was incubated with 
1.5 mM xanthine, 33 munit/ml xanthine oxidase 
and 0.1 mM GSH as in Figure 1-2. At the times 
indicated, an aliquot of the reaction mixture 
was stopped by adding 40 mM iodoacetamide for 
electrofocusing and another aliquot was 
stopped with perchloric acid for glutathione 
analysis. S-thiolation was quantitated by gel 
densitometry as described for Figure 1-2 
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mechanism could not result from an exchange reaction with 
glutathione disulfide. 
Mechanism of S-Thiolation 
Superoxide anion is one of the prominent oxyradicals 
produced by xanthine oxidase that can be quantitated by the 
reduction of ferricytochrome c. Table I-l shows that both 
creatine kinase and glycogen phosphorylase b could inhibit 
the reduction of ferricytochrome c by superoxide anion 
under conditions similar to those used in our protein 
modification experiments. In protein modification 
experiments creatine kinase was normally present at 12 nM 
and phosphorylase b at 3 joM. These proteins were 
significantly more effective than reduced glutathione as 
inhibitors of ferricytochrome c reduction. Since neither 
protein caused a significant reduction in the rate of uric 
acid production by xanthine oxidase (data not shown), 
inhibition of the xanthine oxidase reaction could not 
account for the observed decrease in reduction of 
ferricytochrome c. This result suggests that superoxide 
anion might react preferentially with protein 
sulfhydryls in the presence of excess glutathione. Table 
I-l also shows that ascorbate was also an effective 
inhibitor of ferricytochrome c reduction. Therefore, it 
might be an effective inhibitor of oxyradical- or H2O2-
55 
Table I-l. Inhibition of superoxide anion-dependent 
reduction of ferricytochrome c by glutathione, 
proteins, and ascorbate. 
The rate of superoxide anion production by 33 
munit/ml xanthine oxidase in air-saturated B-
glycerophosphate buffer, pH 7.0, containing 1.5 
mM xanthine was measured with 40 pM 
ferricytochrome c as described by Johnston 
(25). The rate of ferricytochrome c reduction 
with no additions was 25 joM per minute. 
Additions to the reaction are as indicated 
ADDITIONS % INHIBITION OF CYTOCHROME c 
REDUCTION 
CREATINE KINASE 
3 pM 
6 pM 
12 pM 
31 
50 
55 
PHOSPHORYLASE b 
3 pM 
6 HM 
10 pM 
18 
35 
41 
GSH 
0.1 mM 
0.3 mM 
1.0 mM 
2.0 mM 
0 
4 
6 
8 
ASCORBATE 
10 pM 
50 pM 
100 pM 
15 
18 
35 
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initiated protein S-thiolation as well. Ascorbate at the 
concentrations of 50 pM and 100 pM inhibited 22% and 51% of 
S-thiolation of creatine kinase, respectively. Thus, these 
experiments strongly suggest some role of superoxide anion 
in the generation of an active protein species that leads 
to S-thiolation. 
Further attempts at using various inhibitors of 
specific reduced oxygen species to clarify the mechanism of 
oxyradical- or H202-initiated protein S-thiolation were not 
conclusive. Some variability in the effect of catalase and 
superoxide dismutase was observed, but S-thiolation was 
partially inhibited by catalase (150 units/ml) and this 
catalase inhibition was further potentiated by superoxide 
dismutase (50 pg/ml) (data not shown). Therefore, it is 
likely that both superoxide anion and hydrogen peroxide 
contribute to S-thiolation of protein. This reaction 
system is quite complex and several reduced oxygen species 
species may contribute to protein S-thiolation. 
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DISCUSSION 
This study was initiated in order to understand 
processes by which protein S-thiolation might occur in 
vivo. Much evidence has accumulated to suggest that 
extensive oxidation of cellular glutathione can result in 
protein S-thiolation (14,17). It has also been 
demonstrated that many proteins may be specifically S-
thiolated by thiol-disulfide exchange with glutathione 
disulfide (8,9,27-29). These results suggested that 
protein S-thiolation in vivo may be directly related to the 
oxidation of glutathione. Oxidation of glutathione can 
occur by nonenzymatic oxidation in oxyradical- or H2O2-
initiated processes (30,31), by drug related non-radical 
processes (32,33), and by the enzyme-catalyzed reduction of 
hydrogen peroxide, i.e., glutathione peroxidase (34). 
Several studies have shown that very active oxidation of 
glutathione by these mechanisms in vivo may not lead to 
high intracellular concentrations of GSSG since 
accumulation of this species is prevented by the action of 
glutathione reductase (35) and GSSG-specific ATP-dependent 
membrane transport (36). Thus, an alternative mechanism of 
protein S-thiolation that could account for protein S-
thiolation without extensive glutathione oxidation would 
make its importance in metabolic regulation more plausible. 
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Protein modification initiated by direct oxyradical attack 
on protein sulfhydryls provides an attractive alternative 
to thiol-disulfide exchange. This process may occur with 
little oxidation of glutathione and with the same 
specificity as thiol-disulfide exchange. 
The experiments in this report suggest that 
oxyradical- or H2O2-initiated protein S-thiolation has 
several features that support its possible metabolic 
importance. First, amino acids possessing reactive 
sulfhydryl groups may be the only amino acids modified by 
oxyradical- or H^O^-initiated processes. Thus, as shown in 
experiments with creatine kinase, the cellular 
concentration of glutathione may be an important factor in 
the generation of S-thiolated proteins. On the other hand, 
phosphorylase b did not seem to be affected greatly by 
changes in glutathione concentration. These limited 
experiments suggest that cellular glutathione concentration 
may have important relationships with the extent of 
modification of different proteins by S-thiolation during 
oxidative stress, and depletion of cellular glutathione 
could have major effects on oxyradical- or H2O2-initiated 
S-thiolation of proteins. These facts may be explained by 
a mechanism in which protein sulfhydryls are activated by 
reaction with reduced oxygen species, and then the 
activated proteins react with reduced glutathione or with 
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oxygen. Second, extensive protein S-thiolation may occur 
under conditions that lead to only a minimal oxidation of 
glutathione (Figures 1-3 and 1-4), suggesting that specific 
protein S-thiolation in vivo may not require strongly 
oxidizing conditions leading to extensive oxidation of 
glutathione. Third, the oxyradical- or H^Og-initiated 
process is rapid enough to be of metabolic significance. 
The rates of S-thiolation by this mechanism are adequate to 
account for the rates of S-thiolation we observed in 
cultured heart cells (24) . 
Since it is recognized that oxyradicals are generated 
by processes initiated by drug metabolism (37-39), 
mitochondrial electron transport (40-42), membrane-
stimulated oxidases (43-45), or inflammatory reactions 
(46,47), there may be different occasions in which 
oxyradical-initiated protein S-thiolation becomes a factor 
in cellular responses. These events may be very site-
directed in vivo, since the reactivity of radicals suggests 
that they do not diffuse far before participating in a 
chemical reaction (48). One might expect that the proteins 
affected by drug metabolic processes may be different from 
those affected by inflammatory reactions or mitochondrial 
electron transport. 
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ABSTRACT 
The role of thioredoxin in the reduction of protein 
mixed-disulfides (dethiolation) was studied by 
electrofocusing methodology with glycogen phosphorylase b 
and creatine kinase as substrates for the reaction. 
Glycogen phosphorylase b was effectively dethiolated by 
Escherichia coli thioredoxin with dithiothreitol as the 
reductant, while creatine kinase could not be dethiolated 
by this mechanism. The rate of dethiolation of 
phosphorylase b was dependent on the concentration of 
thioredoxin up to a maximum at 20 joM when the concentration 
of phosphorylase b was 4 pM in monomer. Rat heart 
contained a thioredoxin reductase activity that could use 
added ^  coli thioredoxin to dethiolate phosphorylase b, 
and the same concentration of thioredoxin as above was 
required. This activity was not expressed with creatine 
kinase as the substrate. Cardiac tissue was shown to have 
a similar endogenous dethiolating activity. These results 
suggest that thioredoxin may play an important role in 
dethiolating specific proteins that might become S-
thiolated during oxidative stress of cardiac tissue. 
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INTRODUCTION 
Thioredoxin has been shown to act as a reducing agent 
in enzymes such as ribonucleotide reductase (1,2) and 
methionine sulfoxide reductase (3). It is also a reductive 
activation factor for glucocorticoid receptor (4) and 
enzymes such as chloroplast fructose-1,6-bisphosphatase 
(5,6), NADP-malate dehydrogenase (6,7), and vitamin K 
epoxide reductase (8). Thioredoxin shows a broad 
specificity for reduction of disulfide bonds in low 
molecular weight disulfides and protein disulfides (9-12). 
A well-known example is reduction of insulin (11,12) in a 
reaction that has been used to assay thioredoxin. 
Dethiolation, i.e., regeneration of reduced proteins 
from S-thiolated proteins (protein mixed-disulfides), is 
one kind of disulfide reduction that occurs in proteins 
containing single reactive sulfhydryls. Our previous 
studies show that many proteins are S-thiolated in cardiac 
cells under the oxidative stress (13-15), and dethiolation 
of these proteins was very active (15). Glutathione-
dependent dethiolation by thioltransferase or glutaredoxin 
has been shown in many experiments (16,17). These two 
proteins are part of a family of proteins containing a 
dithiol active site. This protein family also includes 
thioredoxin. Even though it has been suggested that 
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thioredoxin may be involved in protein dethiolation, direct 
evidence for this role of thioredoxin has not been 
available. In this paper, thioredoxin-dependent 
dethiolation of two important enzymatic proteins was 
studied, using recombinant Escherichia coli thioredoxin as 
a model protein for this process. This study shows that 
creatine kinase is not dethiolated by a thioredoxin-related 
mechanism, while phosphorylase b is an active substrate for 
this process. 
68 
MATERIALS AND METHODS 
Materials 
Rabbit muscle glycogen phosphorylase b, bovine heart 
creatine kinase, iodoacetamide, sodium iodoacetate, NADPH, 
and dithiothreitol were obtained from Sigma Chemical 
Company, St. Louis, MO, U.S.A. Escherichia coli 
recombinant thioredoxin was from Calbiochem, La Jolla, CA, 
U.S.A. Ampholytes were from Pharmacia LKB, Piscataway, NJ, 
U.S.A. GelBond was from FMC Corp., Rockland, CA, U.S.A. 
HPLC ion exchange column, Bio-Gel TSK DEAE-5PW (75x7.5 mm) 
was from Bio-Rad Laboratories, Richmond, CA, U.S.A. 
Preparation of S-thiolated glycogen phosphorvlase b and 
creatine kinase 
Glycogen phosphorylase b was treated with 10 mM 
dithiothreitol, 2 mM EDTA, 10 mM Tris-HCl, pH 8.0, for 30 
minutes at 30°C and dialyzed against 20 mM B-
glycerophosphate, pH 7.0. This phosphorylase b was then S-
thiolated by reaction with 10 mM glutathione disulfide, pH 
8.0, for 5 hours at room temperature and then, overnight at 
4°C. Creatine kinase was treated similarly, but it was S-
thiolated with 40 mM glutathione disulfide. 
S-thiolated phosphorylase b was dialyzed against 10 mM 
Tris-HCl, pH 7.8, and fractionated by HPLC with a Bio-Gel 
TSK DEAE-5PW column (75x7.5 mm) equilibrated with the same 
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buffer, by using a 0-100 mM NaCl gradient. S-thiolated 
creatine kinase was dialyzed against 10 mM Tris-HCl, pH 
8.5, and fractionated by HPLC ion exchange with a 0-50 mM 
NaCl gradient, in pH 8.5 Tris-HCl. Fully S-thiolated 
protein fractions were identified by electrofocusing and 
concentrated by dialyzing against 20 mM 6-glycerophosphate 
containing 50% glycerol. All dialysis tubing was 
pretreated with 10 mM sodium bicarbonate and 1 mM EDTA. 
Purified proteins were kept at -20°C in 20 mM 6-
glycerophosphate, 50% glycerol. 
Preparation of rat heart extract 
Rat heart was frozen immediately after removal by 
clamping with liquid nitrogen cooled-tongs. Tissue was 
powdered in a percussion mortar in liquid nitrogen and 
homogenized with four volumes of 50 mM Tris-HCl, 5 mM EDTA, 
pH 7.8. The supernatant after centrifuging at 15,000xg for 
30 minutes was dialyzed against 20 mM 6-glycerophosphate, 
pH 7.0, overnight with one buffer change in pretreated 
dialysis tubing with molecular weight cutoff 3,500 
(Spectra/Por, Fisher Scientific). 
Analysis of protein dethiolation 
S-thiolation and dethiolation of proteins were 
analyzed by electrofocusing as described previously (18). 
All reactions contained 4 joM phosphorylase b and/or 7 juM 
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creatine kinase (in monomer concentration) in 20 mM 6-
glycerophosphate, 2 mM EDTA, pH 7.0. Protein samples were 
alkylated with 40 mM iodoacetamide for 15 minutes before 
focusing on polyacrylamide gels with 4% T-2.6% C containing 
2% of a mixture of five volumes of preblended pH 5-8 and 
one volume of pH 4-6 LKB Ampholytes. Gels were prefocused 
for 10 minutes, samples were applied in sample wells 
approximately 2.0 cm from anode, and then focused for 50 
minutes at 5°C with limiting voltage, 1,500 V, and limiting 
current, 2.8 mA/cm gel width. Gels were stained as 
described (18). 
Analvsis of reduction status of E. coli thioredoxin 
Samples containing ^  coli thioredoxin were alkylated 
with 100 mM sodium iodoacetate, pH 8.5, for 15 minutes and 
focused on a polyacrylamide gel containing a 2% mixture of 
equal amounts of pH 3-5 and pH 4-6 LKB Ampholytes. 
Focusing conditions were as described above. 
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RESULTS AND DISCUSSION 
It has been shown that thloredoxin is capable of 
reducing disulfide bonds in low molecular weight disulfides 
and protein disulfides in studies that used indirect 
methods for the assay of reduction (9-12). In this paper, 
we used an electrofocusing method to determine the rate of 
reduction of S-thiolated proteins. Glycogen phosphorylase 
b and creatine kinase were selected for this study because 
they could be obtained in very pure form and because each 
protein focused at different pH's according to the degree 
of dethiolation (18). Both proteins have been shown to be 
potentially S-thiolated in situ (15). Glycogen 
phosphorylase b and creatine kinase were S-thiolated and 
purified as described in Materials and Methods. Purified 
proteins were fully reducible by dithiothreitol and showed 
no reaction with iodoacetate indicating these proteins were 
fully S-thiolated. 
S-thiolated proteins were reduced by dithiothreitol in 
a concentration-dependent manner, and creatine kinase was 
more reactive than phosphorylase b with dithiothreitol. A 
fivefold or sixfold molar excess of dithiothreitol showed 
no dethiolation of phosphorylase b but showed limited 
dethiolation of creatine kinase. At least a fiftyfold 
excess was required for dethiolation of phosphorylase (data 
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not shown). This result showed that a low concentration of 
dithiothreitol could be used as a reductant to study the 
effect of Escherichia coli thioredoxin on dethiolation of 
proteins. Figure II-l shows dethiolation of phosphorylase 
b (lanes 1-4) and creatine kinase (lanes 5-8) by coli 
thioredoxin in the presence of dithiothreitol. Lanes 1 and 
5 show the positions of fully S-thiolated phosphorylase b 
and creatine kinase, respectively. Lanes 2 and 6 show the 
positions of fully reduced phosphorylase b and creatine 
kinase, respectively. Phosphorylase b, depending on the 
degree of S-thiolation, can focus as five separate bands 
since it is a homodimer with two reactive sulfhydryls on 
each subunit. As the S-thiolated protein becomes more 
dethiolated, bands appear at a more basic pH. Lane 3 shows 
phosphorylase bands at the most acidic pH (fully S-
thiolated protein) and at the first band formed on 
dethiolation. Lane 4 shows the next two protein bands in 
the dethiolation of phosphorylase b. Creatine kinase is a 
homodimer with a reactive sulfhydryl group on each subunit, 
and it focuses as three separate bands. Lanes 7 and 8 show 
all these bands. In lanes 3 and 7, purified fully S-
thiolated phosphorylase b and creatine kinase, 
respectively, were treated with 30 pM dithiothreitol. And 
in lanes 4 and 8, each protein was incubated with 30 pM 
thioredoxin in the presence of 30 joM dithiothreitol. This 
Figure II-l. Dethiolation of glycogen phosphorylase b and 
creatine kinase by E^. coli thioredoxin. 
Lanes 1-4 show the reactions with S-thiolated 
phosphorylase b as substrate and, lanes 5-8 show 
the reactions with S-thiolated creatine kinase. 
Lanes 1 and 5 show the positions of fully S-
thiolated proteins, and in lanes 2 and 6, each S-
thiolated protein was incubated with 10 mM 
dithiothreitol (DTT) to reduce proteins completely. 
In lanes 3 and 7, 4 pM of S-thiolated phosphorylase 
b and 7 pM of S-thiolated creatine kinase (in 
monomer concentration), respectively, were 
incubated with 30 pM dithiothreitol at pH 7.0 for 
30 minutes at 30°C. In lanes 4 and 8, S-thiolated 
proteins were incubated with 30 pM coli 
recombinant thioredoxin and 30 pM dithiothreitol 
under the same conditions. The reactions were 
started by adding S-thiolated phosphorylase b or 
creatine kinase and stopped by addition of 40 mM 
iodoacetamide. In this figure and following 
figures, the cathode is at the top. The 
isoelectric points (pi's) of proteins are as 
follows, S-thiolated phosphorylase b, 5.8; reduced 
phosphorylase b, 6.1; S-thiolated creatine kinase, 
6.2; reduced creatine kinase, 6.4 
PHOSPHORYLASE b  
1 2  3  4  
REDUCED-
S -TH IOLATED 
«Hi 
# 
CREATINE  K INASE 
5  6  7  8  
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S -TH IOLATED 
+  DTT (30  j jM )  
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+ + 
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concentration of dithiothreitol had almost no effect on S-
thiolated phosphorylase b, however, the addition of 30 pM 
E. coli thioredoxin enhanced dethiolation greatly (compare 
lanes 3 and 4). Thioredoxin had no effect on phosphorylase 
b without dithiothreitol (see Figure II-4). In contrast, 
creatine kinase was partially reduced by 30 pM 
dithiothreitol, and the addition of thioredoxin did not 
enhance dethiolation of creatine kinase. No reaction 
conditions were found in which thioredoxin stimulated 
dethiolation of creatine kinase. 
The lack of dethiolation of creatine kinase by 
thioredoxin could be attributed to inhibitory contaminants 
that might be present in the creatine kinase preparation. 
Such contaminants are known to have significant effects on 
the rate of the reaction of sulfhydryl groups. If 
phosphorylase and creatine kinase were mixed and 
dethiolation was studied in this mixture, inhibitory 
contaminants in creatine kinase should affect the rate of 
dethiolation of phosphorylase. Figure II-2 shows such an 
experiment done under the same conditions as in Figure II-
1. Lane 1 of Figure II-2 shows the mixture of fully S-
thiolated creatine kinase (band a) and fully S-thiolated 
phosphorylase b (band b), and lane 2 shows the mixture of 
reduced creatine kinase (band c) and reduced phosphorylase 
b (band d). In lane 3, the mixture was incubated with 30 
Figure II-2. Dethiolation of glycogen phosphorylase b and 
creatine kinase in a single reaction mixture. 
Lane 1 shows the mixture of S-thiolated creatine 
kinase (band a) and S-thiolated phosphorylase b 
(band b), and lane 2 shows the mixture of reduced 
creatine kinase (band c) and phosphorylase b (band 
d). In lanes 3 and 4, a mixture of S-thiolated 
phosphorylase b and S-thiolated creatine kinase was 
incubated with the additions indicated at pH 7.0, 
for 30 minutes at 30°C. In lane 5, phosphorylase b 
was incubated with additions indicated under the 
same conditions. All the samples were alkylated 
with 40 mM iodoacetamide after the reaction 
D T T ( 3 0  j u M )  
THI0RED0XIN(30 jjM) 
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pM dithiothreitol, and in lane 4, 30 pM ^  coli thioredoxin 
was added to the 30 pM dithiothreitol. Lane 5 shows the 
control reaction of S-thiolated phosphorylase b alone in 
this experiment. Results are identical to those in Figure 
II-l. Thus, the absence of thioredoxin-catalyzed 
dethiolation of creatine kinase could not be attributed to 
protein contaminants. In addition, the rate of 
dethiolation of phosphorylase b was not affected by the 
presence of creatine kinase (compare lane 4 with lane 5). 
These results suggest that phosphorylase b can be 
dethiolated by thioredoxin system but creatine kinase is 
not a substrate for thioredoxin-dependent dethiolation. 
The mechanism of phosphorylase dethiolation could be 
studied by comparing the reduction state of thioredoxin 
with that of phosphorylase during the active dethiolation 
of phosphorylase. Figure II-3 compares these two proteins 
by electrofocusing. Phosphorylase b was incubated with 30 
pM thioredoxin and 30 pM dithiothreitol under the same 
conditions as in Figure II-l. At the indicated times, one 
aliquot of reaction mixture was treated with iodoacetamide, 
and a second aliquot was treated with iodoacetate. ' The 
sample treated with iodoacetamide was focused to determine 
the rate of dethiolation of phosphorylase b. The sample 
treated with iodoacetate was used for analysis of 
thioredoxin on a separate electrofocusing gel. Reduced and 
Figure II-3. Dethiolation of glycogen phosphorylase b and 
reduction status of coli thioredoxin. 
S-thiolated phosphorylase b was incubated with 30 
joM coli thioredoxin and 30 pM dithiothreitol at 
pH 7.0, 30°C, and at the indicated times, an 
aliquot of the reaction mixture was alkylated with 
iodoacetamide and a second aliquot was alkylated 
with 100 mM sodium iodoacetate. The samples 
alkylated with iodoacetamide were analyzed for 
dethiolation of phosphorylase b on a 
electrofocusing gel with a mixture of pH 5-8 
preblended ampholytes and pH 4-6 ampholytes as 
described in Materials and Methods (top figure). 
The samples alkylated with sodium iodoacetate were 
analyzed for the reduction state of thioredoxin on 
the gel containing pH 3-5 and pH 4-6 ampholytes. 
The isoelectric point (pi) of oxidized thioredoxin 
in this figure is 4.3 (bottom figure) 
REDUCED 
-THIOLATED 
OXIDIZED 
REDUCED 
PHOSPHORYLASE b  
THIOREDOXIN 
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oxidized thioredoxin could easily be separated on this gel 
when alkylated with iodoacetate so that reduced thioredoxin 
carried two additional negative charges. Thus, reduced 
thioredoxin focused with a more acidic pi than the oxidized 
form. In the experiment shown, phosphorylase b was 
gradually dethiolated, but thioredoxin maintained a 
constant reduction state throughout the reaction. This 
result suggests that the rate of dethiolation of 
phosphorylase b was determined by the rate of the reaction 
between the reduced form of thioredoxin and S-thiolated 
phosphorylase b. 
The concentration of thioredoxin required for 
phosphorylase dethiolation also provides important 
mechanistic information about this process. Figure II-4 
shows the effect of thioredoxin concentration on 
dethiolation of phosphorylase b at 4 pM of phosphorylase 
monomer concentration (8 pM "reactive" sulfhydryl). Lane 1 
shows fully S-thiolated phosphorylase b, and lane 2 shows 
reduced phosphorylase b. In lanes 3-7, S-thiolated 
phosphorylase b was incubated with various concentrations 
of thioredoxin in the presence of 30 pM dithiothreitol. 
Lane 8 shows the same reaction as lane 7 but with no added 
dithiothreitol. Thioredoxin in the absence of 
dithiothreitol had no effect on phosphorylase b (lane 8). 
The rate of dethiolation of phosphorylase b was dependent 
Figure II-4. Effect of thioredoxin on dethiolation of glycogen 
phosphorylase b. 
Lane 1 shows S-thiolated phosphorylase b and lane 2 
shows reduced phosphorylase b. The concentration 
of phosphorylase b was 4 pM in monomer. In lanes 
3-7, S-thiolated phosphorylase b was incubated with 
the indicated concentration of E_^ coli thioredoxin 
in the presence of 30 pM dithiothreitol (DTT) at pH 
7.0 for 30 minutes at 30°C. In lane 8, S-thiolated 
phosphorylase b was incubated with 30 pM 
thioredoxin in the absence of dithiothreitol. 
After the reaction, samples were alkylated with 40 
mM iodoacetamide and run on pH 5-8/pH 4-6 gel as 
described in Materials and Methods 
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on the concentration of thioredoxin below approximately 20 
pM thioredoxin. The identical experiment with 100 jjM 
dithiothreitol showed the same pattern of thioredoxin 
concentration dependency (data not shown). These data 
suggest that the association of reduced thioredoxin with 
the S-thiolated site in phosphorylase b is a weak 
interaction that requires a high concentration of coli 
thioredoxin. Thioredoxin was a more efficient reducing 
agent than dithiothreitol for the S-thiolated protein, but 
it probably does not function as a true "catalyst" in this 
process because of a high concentration requirement. 
It was of interest to determine if ^  coli thioredoxin 
could act as a protein reductant in a system in which NADPH 
provided the reducing potential. We examined this 
possibility with cardiac tissue extract, which was diluted 
to avoid endogenous dethiolation activity of this kind. In 
Figure II-5A, lanes 3-7 show the effect of added coli 
thioredoxin on the dethiolation of a mixture of creatine 
kinase and phosphorylase b when NADPH was added as the 
reductant. Lane 8 shows the same reaction as lane 7 but 
without cardiac extract, and lane 9 shows the protein bands 
that were present in the cardiac extract alone. An 
extensive and concentration-dependent dethiolation of 
phosphorylase b occurred without significant effect on 
creatine kinase. Thus, the cardiac extract could actively 
Figure II-5. Dethiolation of a mixture of glycogen phosphorylase 
b and creatine kinase by rat heart extract 
supplemented with ^  coli thioredoxin (A) and by 
rat heart extract (B). 
(A); Lanes 1 and 2 show the mixture of S-thiolated 
proteins and the mixture of reduced proteins, 
respectively, as in Figure II-2. In lanes 3-7, a 
mixture of S-thiolated phosphorylase b and S-
thiolated creatine kinase was incubated with 11 pg 
of rat heart extract protein, 0.4 mM NADPH, and 
indicated concentration of E. coli thioredoxin at 
pH 7.0 for 20 minutes at 30®C. In lane 8, a 
mixture of S-thiolated proteins was incubated with 
30 pM coli thioredoxin and 0.4 mM NADPH under 
the same conditions. Lane 9 shows the protein 
bands in the same amount of extract used for the 
reactions in lanes 3-7. 
(B); Bands a, b, c, and d indicate the proteins 
described in (A). In lane 1, a mixture of S-
thiolated phosphorylase b and creatine kinase was 
incubated with 55 pg of rat heart extract protein 
at pH 7.0 for 20 minutes at 30°C. In lane 2, a 
mixture of S-thiolated proteins was incubated with 
55 pg of rat heart extract protein and 0.4 mM NADPH 
under the same conditions. Lane 3 shows the bands 
from rat heart extract in the same amount as used 
in lanes 1 and 2. In these experiments, 4 pM of 
phosphorylase b and 7 pM of creatine kinase 
(concentration of monomer) were used 
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dethiolate phosphorylase b with supplemented ^  coli 
thioredoxin. This result suggests that rat heart probably 
contains a significant thioredoxin reductase activity and 
supplementation with coli thioredoxin expressed this 
activity as the NADPH-dependent dethiolation of 
phosphorylase b. The rate of dethiolation was limited by 
the amount of thioredoxin added to the rat heart extract. 
The rate of phosphorylase dethiolation by thioredoxin-
supplemented cardiac extract reached a maximum at 20 pM 
thioredoxin in agreement with the experiments using 
dithiothreitol as the source of reducing equivalents 
(Figure II-4). NADPH-dependent dethiolation could also be 
demonstrated in unsupplemented cardiac extract if more 
concentrated extract was used in the incubation. Thus, 
Figure II-5B shows that a fivefold increase in cardiac 
extract produced an active NADPH-dependent dethiolation of 
phosphorylase b without ^  coli thioredoxin (lane 2). 
Lane 3 shows the protein bands present in the cardiac 
extract at the concentration used in lanes 1 and 2. The 
degree of dethiolation with 11 jig of extract protein 
supplemented with 20 pM coli thioredoxin (Figure II-5A, 
lane 6) was almost same as dethiolation by 55 pg of extract 
protein without thioredoxin supplementation (Figure II-5B, 
lane 2). Additional experiments have shown that the 
endogenous NADPH-dependent activity of cardiac tissue 
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requires two components, a low molecular weight protein 
(i.e., less than 16 kDa) and high molecular weight 
component. These properties suggest a thioredoxin-like 
reduction system in the cardiac extract. 
The results of these experiments show that glycogen 
phosphorylase b is dethiolated effectively by both coli 
thioredoxin and a suspected cardiac thioredoxin-like 
protein. On the other hand, creatine kinase was not a 
substrate for this dethiolation system. The rate of 
dethiolation of phosphorylase b (obtained by densitometric 
quantitation) in a cardiac extract supplemented with 20 pM 
E. coli thioredoxin was approximately 0.22 nmole/mg 
protein/min. Unsupplemented cardiac extract gave a rate of 
0.04 nmole/mg protein/min. These rates can be compared 
with the activity of glutathione reductase in the same 
tissue, which was 42.5 nmoles/mg protein/min. The maximum 
rate of protein dethiolation by the thioredoxin system 
appears to be a complex function of the concentration of 
both the S-thiolated substrate and thioredoxin. The rate 
of protein dethiolation in cardiac tissue obtained from the 
experiments in this study seems to be underestimated 
because a limited amount of extract protein was used for 
these experiments to avoid interference with substrate 
protein bands by extract proteins. Therefore, a full 
assessment of dethiolation potential of cardiac thioredoxin 
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system awaits a more detailed study with cardiac 
thioredoxin and its endogenous substrate proteins. 
Thioredoxin is known to be present in almost all mammalian 
cells and in many subcellular fractions (19,20), and its 
distribution may be related to the metabolic activities of 
specific tissues (20). The potential for protein 
dethiolation in cardiac tissue remains to be fully explored 
under conditions of oxidative stress or in response to 
changes in thioredoxin content. 
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abstract 
Dethiolatlon of proteins (reduction of protein itiixed-
disulfides) by NADPH-dependent and glutathione (GSH)-
dependent enzymes and by nonenzymatic reaction with reduced 
glutathione (GSH) were studied by electrofocusing 
methodology with glycogen phosphorylase b and creatine 
kinase as substrates. Phosphorylase b was not rapidly 
dethiolated by reduced glutathione alone, but a cardiac 
extract catalyzed rapid dethiolation by both an NADPH-
dependent and a GSH-dependent process. In contrast, 
creatine kinase was actively dethiolated by GSH. This GSH-
dependent dethiolation was not enhanced by a soluble 
extract of bovine heart. Creatine kinase was also not 
dethiolated by an NADPH-dependent process. Partial 
purification of the phosphorylase dethiolases showed that 
the NADPH-dependent dethiolase had both a high molecular 
weight and a low molecular weight component. The 
properties of these components were similar to thioredoxin 
and thioredoxin reductase. These two components were 
sensitive to inhibition by phenylarsine oxide, and 
inhibition was reversed by addition of a dithiol. In 
contrast, GSH-dependent dethiolation required a single 
component of low molecular weight. This process was less 
sensitive to phenylarsine oxide inhibition. These studies 
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show that two cytosolic proteins, phosphorylase b and 
creatine kinase, were dethiolated by different mechanisms. 
Phosphorylase b was dethiolated by both NADPH-dependent and 
GSH-dependent enzymes found in a soluble extract of bovine 
heart. In contrast, creatine kinase was rapidly 
dethiolated nonenzymatically by GSH alone. 
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INTRODUCTION 
It has been shown that oxidative stress stimulates S-
thiolation (mixed-disulfide formation) of many proteins (1-
4). Dethiolation (reduction of protein mixed-disulfides) 
of these proteins can play an important role in the 
cellular defense against oxidative stress. Our previous 
studies showed that all S-thiolated proteins in cardiac 
cells were actively dethiolated and that the rates of 
dethiolation were not equal (4). 
Thiol-disulfide exchange between protein thiols and 
low molecular weight thiols such as glutathione has been 
suggested as a major mechanism of protein S-thiolation and 
dethiolation (5-7). A cytoplasmic enzyme, thioltransferase 
(glutathione:disulfide oxidoreductase), has been known to 
catalyze reduction of protein disulfides and thiol-
disulfide interchange between glutathione and protein 
sulfhydryls (8,9). Glutaredoxin is another low molecular 
weight protein originally known to function as a hydrogen 
donor for reduction of ribonucleotides catalyzed by 
ribonucleotide reductase by using glutathione as a reducing 
agent (10). Glutaredoxin was also shown to reduce some 
disulfides (11). Thioltransferase and glutaredoxin are 
known to have extensive structural similarity, and two 
proteins from the same species are immunologically 
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indistinguishable (12). Thioredoxin is known as a hydrogen 
donor for several enzymes (13-15) and also is known as an 
efficient protein disulfide reductant (16,17). We recently 
demonstrated dethiolation of phosphorylase b by Escherichia 
coli thioredoxin in the presence of very low concentrations 
of dithiothreitol (18). Thioredoxin, glutaredoxin, and 
thioltransferase, which have of around 12,000, are 
classified in a super family of small proteins with 
"vicinal dithiols" in active sites (19). Thiolrprotein-
disulfide oxidoreductase (Mj.=60,000), a membrane-associated 
enzyme that has several names (i.e., glutathione-insulin 
transhydrogenase and protein-disulfide isomerase) is known 
to catalyze the reduction of disulfide proteins by 
glutathione (20-22). 
In this paper, mechanisms of dethiolation by 
nonenzymatic GSH-dependent dethiolation and by enzymatic 
GSH-dependent and thioredoxin-like NADPH-dependent 
dethiolation were studied with S-thiolated glycogen 
phosphorylase b and creatine kinase as substrates. We have 
partially purified these dethiolation protein factors to 
characterize these systems. 
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materials and methods 
Materials 
Rabbit muscle glycogen phosphorylase b, bovine heart 
creatine kinase, reduced and glutathione disulfide, 
iodoacetamide, sodium iodoacetate, NADPH, NADH, and 
dithiothreitol were obtained from Sigma Chemical Company, 
St. Louis, MO, U.S.A. Sephadex G-75-120 and Ampholytes 
were from Pharmacia LKB, Piscataway, NJ, U.S.A. GelBond 
was from FMC Corp., Rockland, CA, U.S.A. HPLC ion exchange 
column, Bio-Gel TSK DEAE-5PW (7.5x75mm) was from Bio-Rad 
Laboratories, Richmond, CA, U.S.A. 
Preparation of S-thiolated alvcoaen phosphorvlase b and 
creatine kinase 
Glycogen phosphorylase b was treated with 10 mM 
dithiothreitol, 2 mM EDTA, 10 mM Tris-HCl, pH 8.0, for 30 
minutes at 30°C and dialyzed against 20 mM 6-
glycerophosphate, pH 7.0. The phosphorylase b was then S-
thiolated by reaction with 10 mM glutathione disulfide, pH 
8.0, for 5 hours at room temperature and then, overnight at 
4°C. Creatine kinase was treated similarly, but it was S-
thiolated with 40 mM glutathione disulfide. 
S-thiolated phosphorylase b was dialyzed against 10 mM 
Tris-HCl, pH 7.8, and then fractionated by HPLC on a Bio-
Gel TSK DEAE-5PW column (7.5x75mm) equilibrated with the 
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same buffer, by using a 0-100 mM NaCl gradient. S-
thiolated creatine kinase was dialyzed against 10 mM Tris-
HCl, pH 8.5, and fractionated by HPLC ion exchange with a 
0-50 mM NaCl gradient, in pH 8.5 Tris-HCl. Fully S-
thiolated protein fractions were identified by 
electrofocusing and concentrated by dialysis against 20 mM 
6-glycerophosphate containing 50% glycerol. All dialysis 
tubing was pretreated with 10 mM sodium bicarbonate and 1 
mM EDTA. Purified proteins were kept at -20°C in 20 mM 6-
glycerophosphate, 50% glycerol. 
Preparation of bovine heart extract 
Bovine heart was extracted with two volumes of 50 mM 
Tris-HCl, 5 mM EDTA, pH 7.8, and centrifuged at 10,000xg 
for 30 minutes. The supernatant was dialyzed in tubing 
with a molecular weight cutoff 3,500 against 20 mM 6-
glycerophosphate, 2 mM EDTA, pH 7.0, overnight with one 
buffer change. 
Partial purification of dethiolation activities from bovine 
heart 
The supernatant from 100 g of bovine heart prepared as 
above was concentrated with 75% ammonium sulfate. The 
ammonium sulfate precipitate was redissolved in a minimum 
volume of 20 mM B-glycerophosphate, 2 mM EDTA, pH 7.0, and 
dialyzed overnight against the same buffer in dialysis 
100 
tubing with molecular weight cutoff 3,500. After 
centrifugation to remove any undissolved material, the 
supernatant was loaded on a Sephadex G-75-120 column 
(2.5x85cm) equilibrated with 20 mM B-glycerophosphate, 2 mM 
EDTA, pH 7.0, and the column was eluted with the same 
buffer. 
Analvsis of protein dethiolation 
S-thiolation and dethiolation of proteins were 
analyzed by electrofocusing as described previously (23). 
All the reactions were carried out in 20 mM 6-
glycerophosphate, 2 mM EDTA, pH 7.0. Protein samples were 
alkylated with 40 mM iodoacetamide for 15 minutes after the 
reaction and analyzed for dethiolation by focusing on 
polyacrylamide gels with 4% T-2.6% C containing 2% of a 
mixture of five volumes of preblended pH 5-8 and one volume 
of pH 4-6 LKB ampholytes. Gels were prefocused for 10 
minutes, alkylated samples were applied in sample wells 
approximately 2.0 cm from anode, and focused for 50 minutes 
at 5°C with limiting voltage 1500 V and limiting current 
2.8 mA/cm gel width. Gels were stained as described 
previously (23). 
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results 
We have studied dethiolation (reduction of protein 
mixed-disulfides) of two cytosolic proteins, glycogen 
phosphorylase b and creatine kinase, by NADPH-dependent and 
glutathione-dependent mechanisms. These two substrate 
proteins were selected because they could be obtained in 
very pure form after HPLC ion exchange chromatography as 
described in Materials and Methods. Dethiolation of these 
proteins could be easily analyzed by electrofocusing 
because each focuses at different pH's, depending on the 
degree of dethiolation (23). Phosphorylase b focuses as 
five different bands because it is a homodimer with two 
reactive sulfhydryls on each subunit, and creatine kinase 
focuses as three different bands because it is a homodimer 
with one reactive sulfhydryl on each subunit. Dethiolation 
causes the proteins to focus at a more basic pH. 
Figure III-l demonstrates the presence of NADPH-
dependent dethiolation activity in a soluble extract of 
bovine heart. Lanes 1 and 2 are fully S-thiolated 
phosphorylase and reduced phosphorylase, respectively. 
Lanes 7 and 8 are S-thiolated and reduced creatine kinase, 
respectively. The result showed that phosphorylase b was 
completely dethiolated by NADPH with added bovine heart 
extract (lane 5), but creatine kinase was not (lane 10). 
Figure III-l. NADPH-dependent dethiolation of phosphorylase b 
and creatine kinase by bovine heart extract. 
Lanes 1-6 show the reactions with phosphorylase b, 
lanes 7-11 show the reactions with creatine 
kinase, and lane 12 shows protein bands from the 
bovine heart extract. In this and following 
experiments, the concentrations of phosphorylase 
and creatine kinase were 3 pM and 6 pM in monomer, 
respectively. The concentration of extract 
protein was 4.8 pg/pl. Lanes 1 and 2 are S-
thiolated and reduced phosphorylase b, 
respectively. In lanes 3-6, S-thiolated 
phosphorylase b was incubated with the additions 
indicated for 20 minutes. Lanes 7 and 8 are S-
thiolated and reduced creatine kinase, 
respectively. In lanes 9-11, S-thiolated creatine 
kinase was incubated with the additions indicated. 
The reactions were carried out in 20 mM 6-
glycerophosphate, 2 mM EDTA, pH 7.0 at 30°C. The 
reactions were started by adding S-thiolated 
phosphorylase b or creatine kinase, and stopped by 
addition of 40 mM iodoacetamide. In this and 
following figures, the cathode is at the top. The 
isoelectric points (pi's) of proteins are as 
follows, S-thiolated phosphorylase b, 5.8; reduced 
phosphorylase b, 6.1; S-thiolated creatine kinase, 
6.2; reduced creatine kinase, 6.4 
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Boiled heart extract lost all the activity (data not 
shown). NADPH alone or extract alone did not have any 
effect on dethiolation of phosphorylase (lanes 3 and 4). 
NADH could not provide reducing power for dethiolation by 
cardiac extract (lane 6). The lack of NADPH-dependent 
dethiolation of creatine kinase was not due to inhibitory 
contaminants in creatine kinase preparation because 
addition of creatine kinase to the reaction with 
phosphorylase b did not have any effect on dethiolation 
(data not shown). Therefore, creatine kinase is a poor 
substrate for NADPH-dependent dethiolation. 
The effect of reduced glutathione (GSH) on S-thiolated 
creatine kinase and phosphorylase b is shown in Figure III-
2A. Creatine kinase was very rapidly dethiolated by low 
concentration of GSH (lanes 1-5), while phosphorylase was 
not (lanes 6-10). Since GSH-dependent dethiolation of 
phosphorylase b could be catalyzed by a bovine heart 
enzyme, the effect of cardiac extract on GSH-dependent 
dethiolation of phosphorylase b was tested. GSH-dependent 
dethiolation of phosphorylase was stimulated by addition of 
bovine heart extract (Figure III-2B, lanes 3 and 4). 
Boiling for 10 minutes destroyed the activity. An 
enzymatic activity was not required for dethiolation of 
creatine kinase by GSH. Thus, these results show that 
cardiac extract catalyzes dethiolation of phosphorylase by 
Figure III-2. Dethiolation by reduced glutathione. 
(A). The reaction with reduced glutathione 
(GSH). Lanes 1-5 show the reaction with 
creatine kinase, and lanes 6-10 show the 
reaction with phosphorylase b. Lanes 1 and 
2 are S-thiolated and reduced creatine 
kinase, respectively. In lanes 3-5, S-
thiolated creatine kinase was incubated as 
in Figure III-l with GSH at the 
concentration indicated. Lanes 6 and 7 are 
S-thiolated and reduced phosphorylase b, 
respectively. In lanes 8-10, S-thiolated 
phosphorylase b was incubated with GSH as 
indicated. 
(B). The effect of cardiac extract. Lanes 
1 and 2 are S-thiolated and reduced 
phosphorylase b, respectively. In lanes 3 
and 4, S-thiolated phosphorylase was 
incubated with 0.5 mM GSH in the absence or 
presence of 4.8 pg/pl bovine heart extract 
protein. See Figure III-l, lane 12 for the 
bands that are due to the extract 
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GSH and that creatine kinase is rapidly dethiolated by GSH 
without catalysis. 
To characterize the NADPH-dependent and GSH-dependent 
catalytic activities of bovine heart, we partially purified 
these two activities. The extract was fractionated by gel 
permeation chromatography as shown in Figure III-3A. 
Fractions were assayed for NADPH-dependent activity, but no 
fraction dethiolated phosphorylase b when assayed alone. 
When fractions were assayed for dethiolation activity in 
the presence of NADPH and fraction 10, fractions 27-45 
showed very rapid dethiolation of phosphorylase b. When 
fractions were assayed for the activity in the presence of 
NADPH and fraction 30, fractions 2-15 showed very rapid 
dethiolation of phosphorylase. This result suggested that 
NADPH-dependent dethiolation activity required two protein 
components. GSH-dependent activity was present in 
fractions 23-48. GSH-dependent activity did not require a 
high molecular weight component. We selected fraction 10 
as the high molecular weight component because fractions 2-
9 were contaminated with protease activity. Fractions 27-
45 were pooled for the low molecular weight activities. 
Figure III-3B and 3C show NADPH-dependent and GSH-dependent 
dethiolation of phosphorylase by partially purified 
components. Lanes 1 and 2 of Figures III-3B and 3C are S-
thiolated and reduced phosphorylase b, respectively. 
Figure III-3. Partial purification of bovine cardiac 
dethiolation factors. 
(A). The elution profile of gel permeation 
chromatography. Bovine heart extract was 
prepared and fractionated on Sepadex G-75-
120 as explained in Materials and Methods. 
Each fraction was 6 ml. The arrow for 
fraction number 10 shows the high molecular 
weight component used in subsequent studies. 
Fractions 27-45 were used as the low 
molecular weight component. 
(B). NADPH-dependent dethiolation of 
phosphorylase b by partially purified high 
molecular weight and low molecular weight 
components. Lanes 1 and 2 are S-thiolated 
and reduced phosphorylase b, respectively. 
In lanes 3-5, S-thiolated phosphorylase b 
was incubated with NADPH and partially 
purified dethiolation components as 
indicated for 20 minutes. Lanes 6 and 7 
show protein bands from high molecular 
weight (2.5 pg/pl) and low molecular weight 
(0.2 )ig/}il) components, respectively. 
(C), GSH-dependent dethiolation of 
phosphorylase b by high and low molecular 
weight components. Lanes 1 and 2 are same 
as in (B). In lanes 3-6, S-thiolated 
phosphorylase b was incubated with GSH and 
partially purified components as indicated 
for 20 minutes. Lane 7 shows protein bands 
from high molecular weight component 
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Figure III-3B shows that the NADPH-dependent dethiolation 
of phosphorylase b requires both a high molecular weight 
and a low molecular weight component (compare lanes 3, 4, 
and 5). Figure III-3C shows that GSH-dependent 
dethiolation of phosphorylase b requires only the low 
molecular weight fraction (compare lanes 3, 4, 5, and 6). 
Since phosphorylase has two types of sulfhydryls with 
different reactivity, we examined the time course of NADPH-
dependent and GSH-dependent dethiolation of phosphorylase b 
by partially purified dethiolation factors (Figure III-4). 
Dethiolation of phosphorylase b was extensive and rapid in 
both processes. The time course shows that 50% 
dethiolation occurs rapidly by both reactions. This 
probably corresponds to the dethiolation of one of the two 
reactive sulfhydryls. Dethiolation of the second site may 
be more rapidly dethiolated by NADPH-dependent process 
since rates were unequal when the protein was more than 50% 
dethiolated. 
The effect of reduced glutathione (GSH) on 
dethiolation of phosphorylase b by partially purified low 
molecular weight fraction is shown in Figure III-5. The 
reaction was saturated above 0.5 mM GSH. The apparent 
for GSH was approximately 15 pM. This process dose not 
seem to dethiolate the second protein sulfhydryl very 
effectively at any GSH concentration. 
Figure III-4. Time course of NADPH-dependent and GSH-dependent 
dethiolation of glycogen phosphorylase b. 
For the NADPH-dependent dethiolation reaction, 
partially purified high molecular weight component 
and low molecular weight component described in 
Figure III-3 were preincubated with 0.2 mM NADPH 
for 5 minutes and S-thiolated phosphorylase was 
added, and at the indicated time, an aliquot was 
alkylated with iodoacetamide. For GSH-dependent 
dethiolation reaction, partially purified low 
molecular weight component was preincubated with 
0.5 mM GSH as above and S-thiolated phosphorylase 
was added, and reaction was stopped at the 
indicated time. The concentrations of proteins 
were same as in Figure III-3. Samples were 
analyzed by electrofocusing and quantitated by gel 
densitometry. The density of each phosphorylase 
band was multiplied by the charge change 
attributed to the position of the band, e.g., 
fully S-thiolated band was multiplied by 0, the 
next bands were multiplied by 1, 2, and 3 in 
order, fully reduced band by 4. These weighted 
densities were summed to obtain the total charge 
change and devided by maximum possible charge 
change of complete dethiolation to get percent 
dethiolation. #, NADPH-dependent dethiolation; 
A, GSH-dependent dethiolation 
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20 minutes. Samples were run on electrofocusing 
gel after alkylation with iodoacetamide. 
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Some proteins involved in reduction of sulfhydryls are 
known to have "vicinal dithiols". Well-known examples are 
thioredoxin and glutaredoxin (19). It has been shown that 
phenylarsine oxide (PAO) reacts selectively with "vicinal 
dithiols" (24). Figure III-6 shows that the NADPH-
dependent dethiolation (A) and the GSH-dependent 
dethiolation (B) of phosphorylase b were inhibited by PAO. 
In this experiment, partially purified low molecular weight 
component was treated with 0 pM, 10 joM, or 100 joM 
phenylarsine oxide and dialyzed to remove unreacted 
phenylarsine oxide. NADPH-dependent dethiolation of 
phosphorylase was very sensitive to PAO inhibition (Figure 
III-6A), and the PAO inhibition was completely reversible 
by an excess of 2,3-dimercaptopropanol. The high molecular 
weight component treated with 100 >aM PAO was also inactive 
(data not shown). In contrast, GSH-dependent dethiolation 
was less sensitive to PAO (Figure III-6B). Direct 
experiments showed that Escherichia coli thioredoxin (a 
protein with "vicinal dithiols", i.e., two closely spaced 
cysteines that can form an internal disulfide with each 
other) reacted with PAO. On the other hand, creatine 
kinase and phosphorylase b (proteins with "isolated 
thiols", i.e., cysteines are too far apart to react with 
each other) did not react with PAO (data not shown). 
Therefore, the results in Figure III-6 suggest that the 
Figure III-6. Effect of phenylarsine oxide on 
dethiolation. 
Lanes 1 and 2 of each gel show S-thiolated 
and reduced phosphorylase b, respectively. 
(A). In lanes 3-5, S-thiolated 
phosphorylase b was incubated with low 
molecular weight component treated with PAO 
(20 minutes at 30°C) at the concentration 
indicated and high molecular weight 
component and 0.2 mM NADPH for 20 minutes. 
(B). In lanes 3-5, S-thiolated 
phosphorylase b was incubated with the low 
molecular weight component treated with PAO 
as above and 0.5 mM GSH 
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high molecular weight and low molecular weight components 
of the NADPH-dependent dethiolase have important "vicinal 
dithiols". GSH-dependent dethiolation activity is 
different from NADPH-dependent low molecular weight 
component since less inhibition was observed with PAO. 
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DISCUSSION 
In this paper, dethiolation of glycogen phosphorylase 
b and creatine kinase was studied. Dethiolation of these 
proteins occurred by three mechanisms, one that was NADPH-
dependent and two that were GSH-dependent. With 
phosphorylase as the substrate, the GSH-dependent mechanism 
required a low molecular weight protein as a catalyst, but 
with creatine kinase, no catalysis was necessary. The 
substrate-specific nature of these initial studies on 
protein dethiolation suggests that the rate of dethiolation 
of individual proteins may be subject to independent 
regulatory factors. That is, dethiolation of creatine 
kinase may be regulated solely by the redox status of the 
glutathione pool. Dethiolation of phosphorylase may be 
influenced by the activity of two different enzymes and by 
the redox status of both glutathione and NADPH. 
Partial purification of dethiolation enzymes from 
bovine heart showed that NADPH-dependent dethiolation 
activity was composed of two components, a high molecular 
weight and a low molecular weight component. The low 
molecular weight component was smaller than 16,000. Both 
components were sensitive to phenylarsine oxide inhibition, 
indicating a role for "vicinal dithiols" in both reactions. 
These results suggest that NADPH-dependent dethiolation 
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activity has characteristics similar to 
thioredoxin/thioredoxin reductase (13). Partial 
purification of GSH-dependent dethiolatlon factor showed 
that, unlike the NADPH-dependent factor, GSH-dependent 
dethiolatlon required a single protein, a low molecular 
weight component. The GSH-dependent dethiolatlon factor 
was less sensitive to phenylarslne oxide inhibition (Figure 
III-6), suggesting that the NADPH-dependent dethiolatlon 
factor and the GSH-dependent dethiolatlon factor are 
different proteins. This GSH-dependent activity may be 
similar to a thioltransferase activity (8) or a 
glutaredoxin activity (11) that has been previously 
described. The rate of dethiolatlon of phosphorylase b by 
the thioredoxln-like enzyme was approximately 0.13 nmole/mg 
protein/min. The rate of dethiolatlon by GSH-dependent 
dethlolase was almost the same. The maximum rate of 
glutathione reduction by the same cardiac extract was 29 
nmole/mg protein/min. Therefore, the rate of protein 
dethiolatlon was only 1% of the rate of glutathione 
reduction. However, the rate of dethiolatlon in this study 
may be somewhat underestimated because the amount of 
phosphorylase b and extract protein that could be used to 
measure dethiolatlon was limited by interference on 
electrofocusing gels by bands from extract protein. Since 
the rate of dethiolatlon is increased by increasing both 
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the phosphorylase and the extract concentration, a more 
accurate measure of the potential rate of protein 
dethiolation will only be possible with more purified forms 
of dethiolation enzymes. We expect the maximum rate of 
dethiolation to be much higher when these experiments are 
possible. 
Our previous study suggested that protein sulfhydryls 
were more reactive than glutathione with oxyradicals and 
that the initial reaction of protein sulfhydryls with 
oxyradicals led to the activation of the protein 
sulfhydryls and a subsequent reaction with the reduced form 
of glutathione (25). This study show that cells have a 
high capacity for dethiolation of S-thiolated proteins by 
both the thioredoxin-like NADPH-dependent system and the 
GSH-dependent system. In normal unstressed cells, the 
concentration of S-thiolated proteins is very low (4,26). 
Since oxyradicals may be generated by metabolic processes 
such as mitochondrial electron transport (27,28) and 
membrane-associated oxidases (29,30), this suggests that 
under these conditions, the dethiolation rate may be 
sufficient to maintain the fully reduced protein status. 
Thus, under normal growth conditions the turnover of S-
thiolated proteins may function as primary cellular 
antioxidant, keeping proteins from irreversible damage. 
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SUMMARY AND DISCUSSION 
The studies in this dissertation explored the possible 
mechanisms by which S-thiolation and dethiolation of 
proteins might occur in vivo. Under normal unstressed 
conditions, the cellular content of S-thiolated proteins is 
almost undetectably low (20,25). The extent of protein S-
thiolation is dramatically increased during oxidative 
stress, and at the same time, the cellular glutathione pool 
is oxidized (17,25,36). Glutathione oxidation is catalyzed 
by glutathione peroxidase using ^ 2^2 oxidizing agent 
(27-29), but it also occurs by nonenzymatic reaction with 
oxyradicals (30-32). Many proteins can be S-thiolated by 
incubation with glutathione disulfide (GSSG) in vitro (37-
38), suggesting that increased protein S-thiolation may be 
due to thiol-disulfide exchange between protein sulfhydryls 
and GSSG (21,47). S-thiolation of proteins by GSH/GSSG 
mixture required high oxidation state of glutathione, i.e., 
50% of S-thiolation required 0.05-5 of GSH/GSSG (38, 
152,153). However, significant protein S-thiolation could 
be observed under less oxidized conditions in in vivo 
studies (25,36). Therefore, an alternative mechanism of 
protein S-thiolation, not requiring oxidation of 
glutathione prior to S-thiolation, might be feasible. The 
evidence for this alternative mechanism of protein S-
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thiolation initiated by direct reaction of protein 
sulfhydryls with oxyradicals is presented in Section I. 
The results showed that the reaction between protein 
sulfhydryls and the GSSG formed during the reaction with 
oxyradicals could not account for the extent of protein S-
thiolation (Figures 1-3 and 4). And also the results 
indicate that protein sulfhydryls seem to react more 
readily with oxyradicals than glutathione does (Table I-l), 
i.e., protein sulfhydryls are as effective as ascorbate in 
inhibition of cytochrome c reduction by superoxide anion. 
Therefore, we proposed the oxyradical-initiated mechanism 
for protein S-thiolation. According to this mechanism, 
protein sulfhydryls react with oxyradicals resulting in an 
activated form of sulfhydryls (such as thiyl radical) 
subsequently reacting with GSH to give the S-thiolated 
protein. Identification of specific oxyradical species 
responsible for the initiation of S-thiolation is very 
difficult. Different oxyradicals are interconvertible by 
very fast reactions (107), therefore, various inhibitors of 
different oxyradicals did not show conclusive results, 
i.e., superoxide dismutase and catalase inhibited S-
thiolation partly. However, superoxide anion (O^) might be 
the most likely oxyradical species to initiate protein S-
thiolation. Table I-l shows that protein sulfhydryls 
efficiently inhibited the reduction of cytochrome c by 
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superoxide anion, which suggested that protein sulfhydryls 
could actively react with superoxide anion. It is 
generally recognized that small free radicals are reactive 
and therefore short-lived, but there is still appreciable 
variation in their reactivity and life time (154). Some 
radicals are sufficiently stable to diffuse some distance 
in the cell, whereas others are so reactive that they react 
within 1 to 5 molecular diameters from their site of 
formation (154,155). Hydroxy1 radical (OH), one of the 
most reactive oxyradicals, is an example of later 
oxyradical species, so that it reacts with any reactive 
species in its neighborhood. On the contrary, superoxide 
anion is an example of a species that may diffuse far 
enough to reach reactive protein sulfhydryls and initiate 
S-thiolation (107). The results of Section I also suggest 
that reactive thiol groups on protein may be the most 
reactive functional group to react with oxyradicals since 
the reduction of disulfide bond in S-thiolated proteins 
regenerated completely functional original reduced proteins 
as long as sufficient amount of GSH was present in the 
initial reaction with oxyradicals. 
Two different substrates, creatine kinase and glycogen 
phosphorylase b, responded differently to the variation of 
GSH concentration in the reaction. S-thiolation of 
creatine kinase was inhibited by GSH, whereas S-thiolation 
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of phosphorylase b was not. This phenomenon can be 
explained by rapid dethiolation of S-thiolated creatine 
kinase by GSH as shown in Section III. Therefore, the 
amount of S-thiolated creatine kinase observed in Figure I-
2 might be the net amount of S-thiolated form resulted from 
quite active turnover of protein by S-thiolation and 
dethiolation reactions at a given concentration of GSH. 
In Sections II and III, possible mechanisms of protein 
dethiolation were studied. Dethiolation by thioredoxin was 
demonstrated in Section II by using recombinant Escherichia 
coli thioredoxin and dithiothreitol as reducing power. 
This study showed an unexpected result that glycogen 
phosphorylase b was very actively dethiolated by 
thioredoxin but creatine kinase was not. The rate of 
phosphorylase b dethiolation was dependent on the 
concentration of thioredoxin and a high concentration 
(i.e., more than molar equivalent) of thioredoxin was 
required. Therefore, these results suggest that 
thioredoxin functions more as an efficient reductant rather 
than as a true catalyst in this process. Dialyzed rat 
cardiac extract could provide reducing power for coli 
thioredoxin-dependent dethiolation in the presence of 
NADPH, supposedly by thioredoxin reductase activity in the 
extract. The rate of dethiolation was limited by the 
amount of thioredoxin added. The rat cardiac extract 
128 
without supplemented coli thioredoxin also dethiolated 
phosphorylase b when a higher concentration of extract 
protein was added. Thus, dethiolation of phosphorylase b, 
expressed as NADPH-dependent in Figure II-5B, was probably 
by a thioredoxin-like protein in the extract. Dethiolation 
by the thioredoxin-like protein was studied in more detail 
in Section III. 
In Section III, different mechanisms for dethiolation 
of glycogen phosphorylase b and creatine kinase were 
studied. Three mechanisms of protein dethiolation, NADPH-
dependent dethiolation by thioredoxin-like protein, 
nonenzymatic dethiolation by GSH, and enzymatic GSH-
dependent dethiolation could be demonstrated. Glycogen 
phosphorylase b was dethiolated by an enzymatic GSH-
dependent mechanism and by an NADPH-dependent mechanism, 
whereas creatine kinase was dethiolated by GSH without 
enzymatic catalysis. Creatine kinase was not dethiolated 
by the NADPH-dependent mechanism. 
NADPH-dependent dethiolation required two protein 
components, one with low molecular weight and the other 
with high molecular weight. On the other hand, enzymatic 
GSH-dependent dethiolation required one low molecular 
weight protein component. Both of the components of the 
NADPH-dependent dethiolation activity were inactivated by 
phenylarsine oxide. GSH-dependent dethiolation enzyme was 
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also inhibited by phenylarsine oxide but to less extent 
than NADPH-dependent dethiolation components. Therefore, 
it is likely that these dethiolation factors contain 
vicinal dithiols at the active sites. These results 
suggest that NADPH-dependent dethiolation activity has 
characteristics similar to thioredoxin/thioredoxin 
reductase and GSH-dependent dethiolation enzyme might be 
similar to thioltransferase or glutaredoxin. 
A principal difference between the two GSH-dependent 
dethiolation mechanisms (nonenzymatic and enzymatic) was in 
the requirement for GSH. The apparent for the enzymatic 
GSH-dependent dethiolation was about 15 pM, whereas 
nonenzymatic GSH-dependent dethiolation required about ten 
times higher concentration of GSH. Therefore, we can 
expect that nonenzymatic GSH-dependent dethiolation would 
be very sensitive to the total amount and the reduction 
state of the glutathione pool, i.e., it would be severely 
inhibited when the concentration of GSH decreases. 
The dethiolation process might be regulated by factors 
such as the availability of NADPH and GSH, but the enzymes 
involved in dethiolation might also be influenced by 
induction or covalent modification under oxidative stress. 
Overall results of these studies show that reactive 
sulfhydryl groups on proteins are very important in 
preventing oxidative damage to proteins. Since sulfhydryl 
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groups are very reactive toward oxyradicals, protein S-
thiolation might be the only modification during the 
initial stages of oxidative stress, preventing deleterious 
irreversible protein damage. Cells have high capacity for 
dethiolation by GSH-dependent and thioredoxin-like NADPH-
dependent system, and it is possible that individual 
proteins may respond differently to dethiolation systems. 
Therefore, we hypothesize that there might be two groups of 
proteins with reactive sulfhydryls playing important roles 
in defense against oxidative stress. One group of proteins 
has very reactive sulfhydryls and is dethiolated very 
efficiently, functioning as a cellular antioxidant. The 
other group of proteins is dethiolated more slowly 
accumulating S-thiolated forms during prolonged oxidative 
stress affecting metabolic regulation. 
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